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The content in this review focuses on sensitive health topics associated with Men’s 
Business. We encourage readers to consider the appropriate dissemination of the 
information contained in this review for their setting and community.  
About this review 
The purpose of this review is to summarise the evidence on the links between male 
sexual health conditions (erectile dysfunction (ED) and low testosterone) and the 
chronic diseases cardiovascular disease (CVD) and type 2 diabetes mellitus 
(T2DM), specifically to: 
• raise awareness about the links between male sexual health and CVD and 
T2DM for Aboriginal and Torres Strait Islander males  
• encourage the inclusion of sexual health assessments as part of a holistic 
approach to the healthcare of Aboriginal and Torres Strait Islander males 
• encourage healthcare providers to consider sexual health problems and 
impacts in the management and prevention of CVD and T2DM among 
Aboriginal and Torres Strait Islander males 
• encourage Aboriginal and Torres Strait Islander males, health workers and 
health professionals to engage in conversations about sexual health 
problems and impacts, especially with regards to prevention and 
management. 
This review uses information taken from journal articles, research reports, 
government reports, national data collections and national surveys that are available 
and can be accessed through the HealthInfoNet’s publication database 
https://healthinfonet.ecu.edu.au/key-resources/publications. The accuracy of the 
identification of Aboriginal and Torres Strait Islander males in health data collections 
varies across the country. Some information is only considered to be sufficient and 
complete for certain states and territories. Please note that the statistics presented 
in this review do not always include all states and territories, see sources for full 
details. 
The HealthInfoNet, consistent with its nomenclature guide, prefers the term 
‘Aboriginal and Torres Strait Islander’ rather than ‘Indigenous Australian’ for its 
publications. Also, some sources may only use the terms ‘Aboriginal only’ or ‘Torres 
Strait Islander only’. However, when referencing information from other sources, 
authors may use the terms from the original source. As a result, readers may see 
these terms used interchangeably in some instances. If they have any concerns, 
they are advised to contact the HealthInfoNet for further information. 
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What is sexual health? 
The World Health Organization (WHO) defines sexual health as ‘a state of 
physical, emotional, mental and social well-being in relation to sexuality; it is not 
merely the absence of disease, dysfunction or infirmity. Sexual health requires a 
positive and respectful approach to sexuality and sexual relationships, as well as 
the possibility of having pleasurable and safe sexual experiences, free of coercion, 
discrimination, and violence. For sexual health to be attained and maintained, the 
sexual rights of all persons must be respected, protected and fulfilled.’ (World 
Health Organization, 2020a). 
     Sexual health encompasses reproductive health, which the WHO defines as ‘a 
state of complete physical, mental and social well-being and not merely the 
absence of disease or infirmity, in all matters relating to the reproductive system 
and to its functions and processes' (World Health Organization, 2020b). 
 
In recent years, some health indicators for Aboriginal and Torres Strait Islander people 
have improved. While there are ongoing challenges in closing the gap1 (Australian 
Indigenous HealthInfoNet, 2021), health and wellbeing programs for Aboriginal and Torres 
Strait Islander people, and for men specifically, have shown some success when they have 
incorporated appropriate social and cultural approaches (Thomson, Midford, Debuyst, & 
MacRae, 2010; Wenitong, 2002). In fact, there is increasing recognition of the importance 
of addressing cultural as well as social determinants of health for Aboriginal and Torres 
Strait Islander people (Australian Government Department of Health, 2019; Gee, Dudgeon, 
Schultz, Hart, & Kelly, 2014; National Aboriginal Community Controlled Health 
Organisation, 2013). 
Aboriginal and Torres Strait Islander people have specific experiences and needs with 
respect to their health, with high rates of chronic diseases, such as cardiovascular disease 
(CVD) and type 2 diabetes mellitus (T2DM), and high levels of risk factors for these 
diseases such as obesity and smoking (Australian Indigenous HealthInfoNet, 2020; Burrow 
& Ride, 2016; Merone, Burns, Poynton, & McDermott, 2019). Poor access to health 
services and programs can also be the experience of many Aboriginal and Torres Strait 
Islander communities, particularly in remote areas (Australian Institute of Health and 
Welfare, 2020a; Wenitong, Adams, & Holden, 2014).  
Several reports and papers draw attention to the fact that Aboriginal and Torres Strait 
Islander males2 face health challenges, including a low life expectancy relative to other 
population groups (Australian Government Department of Health, 2020; Australian 
Government Department of Health and Ageing, 2010a, 2010b; Australian Institute of Health 
and Welfare, 2012; Prehn & Ezzy, 2020; Thomson et al., 2010; Wenitong, 2002; Wenitong et 
al., 2014). To address the health needs of males, gender-specific approaches that encompass 
the role of males in Aboriginal and Torres Strait Islander communities, are likely to be the most 
effective (Australian Government Department of Health, 2020; Australian Government 
 
1  ‘Closing the gap’ is a term used to describe the strategies used by various levels of government in Australia 
to decrease the difference of health outcomes (such as life expectancy and prevalence of disease) for 
Aboriginal and Torres Strait Islander people and other Australians which has historically been in deficit 
(Department of the Prime Minister and Cabinet, 2020). 
2  The terms 'men' and 'males' are used interchangeably throughout the report. 'Male' is the preferred term as 
it is inclusive of all males, encompassing young males, uninitiated males of any age, adult men and 
members of the LGBTIQA+ community including ‘brotherboys’ and ‘sistergirls’. The term 'men' is used 
where this is the term used in the original source document, and is the term most often used for non-
Indigenous adult males. 
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Department of Health and Ageing, 2010a, 2010b; Australian Institute of Health and Welfare, 
2012; Thomson et al., 2010; Wenitong, 2002; Wenitong et al., 2014). In 2002, the first 
comprehensive report on the health of Aboriginal and Torres Strait Islander males was 
published, entitled Indigenous Male Health: A report for Indigenous males, their families and 
communities, and those committed to improving Indigenous male health (Indigenous male 
health report) (Wenitong, 2002). This report documented the wide range of health issues 
experienced by Indigenous males and highlighted the many gaps in knowledge and research 
on male-specific health (Wenitong, 2002). Importantly, the review included the strengths and 
successes of many Aboriginal and Torres Strait Islander males and gave examples of 
programs providing culturally appropriate services that have resulted in improved access to 
health care (Wenitong, 2002). In 2010, the Australian Indigenous HealthInfoNet’s Review of 
Indigenous male health (Thomson et al., 2010) also documented the extent and range of 
health issues experienced by Aboriginal and Torres Strait Islander males and stressed that 
the social and cultural context of male health and wellbeing must be considered for any health 
promotion or healthcare program to be successful. Moreover, the review highlighted 
improvements in some male health outcomes over a period of several years prior to the 
review, notably for infectious diseases and life expectancy (Thomson et al., 2010).  
Despite the many studies and reports on the health of Aboriginal and Torres Strait 
Islander people, including those that focus on males, there is a lack of information on male 
sexual health conditions. This was identified as a major gap in the 2002 Indigenous male 
health report (Wenitong, 2002): 
Diseases specific to males include those of the prostate gland and sex 
organ, male sexual dysfunction, infertility and testicular cancer. For 
almost all of these conditions, no documented literature examining 
prevalence in Indigenous males or Indigenous male perspectives of the 
illnesses could be found. (p. 16) 
There has been only one in-depth study to date of male sexual health disorders among 
Aboriginal and Torres Strait Islander males (M. Adams, 2014; M. J. Adams, Collins, Dunne, 
de Kretser, & Holden, 2013). This 2004-2007 study was undertaken by Dr Michael Adams, 
an Aboriginal and Torres Strait Islander male, with sponsorship provided by Andrology 
Australia (now known as Healthy Male). The study found relatively high rates of certain 
male sexual health problems such as erectile dysfunction (ED), and identified barriers to 
seeking help for such disorders, including limited awareness of sexual health among 
Aboriginal and Torres Strait Islander males (M. J. Adams et al., 2013). There is a pressing 
need for more research to be undertaken in this area.  
Given that chronic conditions such as CVD and diabetes are common among 
Aboriginal and Torres Strait Islander males and they can occur at younger ages than in 
non-Indigenous males (Burrow & Ride, 2016; Merone et al., 2019), there is much scope for 
including sexual health conditions in the assessment and treatment of males attending 
health services. Moreover, there is evidence that lifestyle interventions used for prevention 
and treatment of CVD and T2DM can also improve sexual health, thus providing an extra 
dimension to health promotion and prevention programs (Gupta et al., 2011). However, 
there is often poor knowledge and awareness of male sexual health and the links with 
general health among both health professionals and Aboriginal and Torres Strait Islander 
males (M. Adams, 2014), partly due to sensitivities and taboos about sexual matters, 
resulting in limited opportunities for discussion and intervention (M. Adams, 2014; 
Wenitong et al., 2014).  
Historical, social and cultural context of Aboriginal and Torres Strait 
Islander male health 
When Aboriginal and Torres Strait Islander people are empowered to connect with culture, 
and the importance of physical, emotional, and spiritual health are realised, health and 
wellbeing is enhanced. It is becoming more widely acknowledged that the current health 
status of Aboriginal and Torres Strait Islander people is influenced by the history of 
colonisation and the associated widespread destruction of culture (Dudgeon, Wright, 
Paradies, Garvey, & Walker, 2014; Gee et al., 2014; Paradies, 2016; Prehn & Ezzy, 2020). 
Moreover, the poorer social conditions (relative to non-Indigenous Australians) in which many 
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Aboriginal and Torres Strait Islander people live today, are a result of the damaging effects 
of colonisation over several generations and these are inextricably linked to current health 
(Dudgeon et al., 2014). There are now theoretical and empirical understandings of how the 
historical trauma related to colonisation cause ill-health among Aboriginal and Torres Strait 
Islander people, how it acts across generations and interacts with present-day racism to 
cause further damage to health (Paradies, 2016). Recognising these damaging effects 
emphasises the resilience of Aboriginal and Torres Strait Islander people and their capacity 
to overcome extreme disadvantage (Dudgeon et al., 2014; Thomson et al., 2010).    
Colonisation has had profound effects on Aboriginal and Torres Strait Islander male 
identity in particular, resulting from the loss of male roles as traditional leaders, decision 
makers, father figures and educators (M. Adams, 1998). This has meant that some older 
Aboriginal and Torres Strait Islander males have lost their authority and status, while young 
males may no longer have access to these role-models and cultural teachers, thus 
contributing to poor health and wellbeing over several generations. The loss of male cultural 
roles can leave Aboriginal and Torres Strait Islander males struggling to find their place in 
the community (M. Adams, 1998; Prehn & Ezzy, 2020). In response, some males engage 
in behaviours that are self-destructive and have deep impacts on their physical, emotional 
and spiritual health (M. Adams, 1998; Thomson et al., 2010). To overcome these 
challenges, Aboriginal and Torres Strait Islander males are increasingly finding ways to re-
connect with their culture and taking their place as decision-makers and role models in their 
own families and communities as well as in the broader Australian community (M. Adams, 
1998; Arney & Westby, 2012; Prehn & Ezzy, 2020).     
Current context for Aboriginal and Torres Strait Islander male sexual health 
Data from Adams’ 2004-2007 study (M. Adams, 2014; M. J. Adams et al., 2013), along with 
the high rates of CVD and T2DM, suggest that male sexual health conditions are common in 
Aboriginal and Torres Strait Islander communities. However, seeking or accessing help for 
assessment and treatment of sexual health can be problematic for Aboriginal and Torres 
Strait Islander males (M. Adams, 2014; M. J. Adams et al., 2013; Arney & Westby, 2012; 
Wenitong, 2002; Wenitong et al., 2014). Only about half of the males with moderate to severe 
ED in the Adams’ study reported having sought help or treatment for the condition (M. J. 
Adams et al., 2013). Barriers to seeking help were identified through focus groups and 
interviews (M. Adams, 2014; M. J. Adams et al., 2013). Participants reported that often males 
keep silent about sexual matters and some have feelings of shame and low self-esteem 
related to their sexual health (M. Adams, 2014; M. J. Adams et al., 2013). Furthermore, they 
reported that males tend to speak in ‘roundabout ways’ when discussing sexual health among 
themselves, and some have fears about lack of confidentiality in communities and the stigma 
attached to having a sexual health problem, which can create a barrier to speaking with health 
professionals (M. Adams, 2014; M. J. Adams et al., 2013). Although non-Indigenous 
Australian males also report barriers to seeking help for sexual health problems (Holden et 
al., 2005), there can be a 'cultural distance' between Aboriginal and Torres Strait Islander 
males and healthcare services that makes discussing sexual health with healthcare workers 
more problematic for Aboriginal and Torres Strait Islander males (M. Adams, 2014). The 
study also identified a perception that knowledge of sexual health problems was low among 
males, although many males correctly identified that sexual dysfunction could be related to 
alcohol abuse, smoking, obesity, heart disease and diabetes (M. Adams, 2014). 
It is apparent that the sexual health of Aboriginal and Torres Strait Islander males is 
'shrouded in silence' (M. Adams, 2014) (p. 88). Adams concluded that the silence existed 
across three levels and that changing the context for Aboriginal and Torres Strait Islander 
male sexual health required action across all levels (M. Adams, 2014). The first level is 
research: there is little knowledge about the extent of the problem and ways to manage 
sexual health in Aboriginal and Torres Strait Islander males. The second level is health 
services, where communicating about sexual health may be difficult for both health 
professionals and Aboriginal and Torres Strait Islander male patients. This is partly due to 
reticence to broach sensitive topics and, perhaps, the cultural distance between males and 
their doctors, particularly if the doctor or health professional is a female or non-Indigenous 
person. The third level is silence at the community level, where males generally don't talk 
about their sexual health with their partners or with other males (M. Adams, 2014).  
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The links between cardiovascular disease and type 2 diabetes and 
male sexual health conditions 
Cardiovascular disease (CVD)  
CVD is the broad term used to describe diseases and conditions that affect the heart and 
blood vessels (World Health Organization, 2017). Specific types of CVD include ischemic 
heart disease (IHD), heart failure, cerebrovascular disease (including stroke), peripheral 
vascular disease and rheumatic heart disease (RHD) (World Health Organization, 2016, 
2017). The term also encompasses biomedical factors such as hypertension (high blood 
pressure) and high cholesterol (World Health Organization, 2016).  
Most types of CVD (excluding RHD3) share a common set of risk factors. These 
include: smoking, unhealthy diet, physical inactivity, high alcohol use, hypertension, high 
cholesterol, unhealthy weight, T2DM, chronic kidney disease, depression/social isolation, 
sex, family history of CVD, ethnicity and age (Agostino et al., 2020; Australian Institute of 
Health and Welfare, 2015b; World Heart Federation, 2017).  
CVD presents a significant burden for Aboriginal and Torres Strait Islander people in 
terms of prevalence, hospitalisation and mortality (Australian Indigenous HealthInfoNet, 
2021; Australian Institute of Health and Welfare, 2016b). Evidence shows that the risk of 
CVD starts relatively early for Aboriginal and Torres Strait Islander people, and a 
consensus statement released by leading Australian health organisations in 2020 
recommended Aboriginal and Torres Strait Islander people begin having CVD risk 
assessments at younger ages because of early disease onset (Agostino et al., 2020). 
Type 2 diabetes mellitus 
Diabetes is a complex chronic condition, characterised by hyperglycemia (high blood sugar 
levels) due to insulin resistance or deficiency, that can lead to morbidity, disability, reduced 
quality of life and premature death (Australian Institute of Health and Welfare, 2020b; 
Diabetes Australia, 2011). Type 2 diabetes (also known as type 2 diabetes mellitus - T2DM) 
is the most common form of diabetes. It usually develops in adulthood, although recently it 
has been diagnosed more frequently among children and adolescents (Peña et al., 2020; 
Shaw & Tanamas, 2012).  
This form of diabetes often runs in families, and typically occurs when risk factors such 
as obesity, poor nutrition, and lack of physical activity are present. T2DM can usually be 
controlled through lifestyle modifications such as keeping fit, eating well and not smoking, 
however patients may require insulin treatment over time (Evans, Canuto, Kelly, 
Caperchione, & Macniven, 2020; The Royal Australian College of General Practitioners & 
Diabetes Australia, 2020).  
As T2DM is often diagnosed at a later age, sometimes signs are dismissed as a part 
of ‘getting older’. Often people with T2DM have no symptoms at all. Sometimes by the time 
T2DM is diagnosed, the complications of diabetes may already be present (Diabetes 
Australia, 2015b). These complications can include diseases of the large blood vessels 
(macrovascular disease), such as heart disease and stroke (CVD), and diseases of the 
small blood vessels (microvascular disease), such as kidney disease, eye disease and 
nerve disease (Baker Heart and Diabetes Institute, 2018; Diabetes Australia, 2015a). 
Aboriginal and Torres Strait Islander people experience disproportionately high levels 
of diabetes, and it is a significant factor in the life expectancy gap between Indigenous and 
non-Indigenous Australians (Burrow & Ride, 2016; Straw et al., 2019; The Royal Australian 
College of General Practitioners & Diabetes Australia, 2020). The Royal Australian College 
of General Practitioners (RACGP) and National Aboriginal Community Controlled Health 
Organisation (NACCHO) recommend that all Aboriginal and Torres Strait Islander adults 
 
3  Unlike other types of CVD, RHD occurs when acute rheumatic fever (ARF), an illness that affects the heart, 
joints, brain and skin, leads to permanent damage to the heart valves (Wyber et al., 2020). ARF is caused 
by an untreated bacterial (group A streptococci or GAS) infection of the throat. 
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be screened for T2DM (via blood test) on an annual basis (The Royal Australian College 
of General Practitioners & Diabetes Australia, 2020). 
Male sexual health conditions 
Over the past 15 to 20 years, evidence for links between male sexual health conditions and 
chronic disease has accumulated, with implications for a more holistic approach to care for 
males presenting with either chronic disease or sexual health conditions (Holden, Allan, & 
McLachlan, 2010). Although nearly all of the studies examining the nature of the relationship 
between reproductive health and general health are in non-Indigenous male populations, it 
is likely that the physiological basis of the relationships will apply to all males (M. J. Adams 
et al., 2013). Moreover, the high prevalence of CVD (Merone et al., 2019) and diabetes 
(Burrow & Ride, 2016) among Aboriginal and Torres Strait Islander males, along with a 
relatively young age of onset, suggests that understanding the nature of these relationships 
and the common risk factors for chronic disease and sexual health conditions can provide 
opportunities for treatment and prevention. However, this will require healthcare providers 
and Aboriginal and Torres Strait Islander males to have an awareness of the links between 
sexual health and general health, and secondly, for males to have access to safe spaces 
where sensitive sexual health issues can be discussed in a culturally appropriate setting 
(Wenitong et al., 2014). 
Links between reproductive health and general health are illustrated by substantial 
evidence showing associations between ED and CVD, particularly coronary heart disease 
(CHD; also known as IHD or coronary artery disease (CAD))4 (Holden, Allan, et al., 2010), 
and T2DM (Nehra et al., 2012). Low testosterone (testosterone deficiency or androgen 
deficiency) has also been the subject of investigation, but due to the need to collect a 
fasting serum sample to measure circulating total testosterone and the complexity of 
testosterone assays, there are fewer studies than those related to ED (measured using a 
questionnaire). Nevertheless, associations between low testosterone and T2DM and 
obesity are well described (Gianatti & Grossman, 2019; Grossmann & Matsumoto, 2017; 
Lue, Brant, Shindel, & Bella, 2015). Some studies have also shown that low circulating 
testosterone levels are associated with greater risk of dying from CVD (or all causes), 
independent of other CVD risk factors (Meyer & Wittert, 2018; Yeap, 2018; Yeap, Dwivedi, 
Chih, & Reid, 2019). The focus of this review is therefore ED and low testosterone, and the 
links between these male sexual health conditions and CVD and T2DM5 (please see 
Appendix 1 for further limitations).  
Erectile dysfunction 
Erectile dysfunction (ED) is defined as a consistent or recurrent inability to maintain a penile 
erection sufficient for satisfactory sexual activity and intercourse (a clinical diagnosis). ED 
can have a significant impact on a male's quality of life (and that of his partner) (Healthy 
Male, 2018d; Shindel, Brandt, Bochinski, Bella, & Leu, 2018), and is a common condition 
that increases in prevalence with age (see Appendix 2 for more information on the 
prevalence of ED in Australia). Sexual health conditions are often not talked about by males 
themselves or by healthcare workers and therefore ED can remain untreated if not 
specifically addressed (Shoshany, Katz, & Love, 2017). 
  
 
4  The terms CHD, IHD and CAD are used interchangeably throughout the report. The term chosen, in 
particular instances, reflects the term used in the source document or dataset; for example, the Australian 
Bureau of Statistics uses the term IHD. 
5  Other male sexual health conditions, such as lower urinary tract symptoms (LUTS), also show associations 
with chronic conditions, but the evidence on the nature of the associations is not yet clear (Blanker, 
Bouwman, Voskamp, & Lisman-van Leeuwen, 2016; Bouwman et al., 2015) and is not covered in this 
review.  
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A penile erection involves nerves, blood vessels and smooth muscle in the penis to achieve 
increased blood to flow into the penis, and compression of the veins in the penis to reduce 
blood flowing out (Healthy Male, 2018d; McMahon, 2019; Shindel et al., 2018). In most 
instances, arousal arising from thoughts, physical stimulation, smells, sounds or images is 
needed to achieve an erection. The brain sends messages down the spinal cord to nerves 
leaving the lower part of the spinal cord. Sensations around the penis, such as touch, can 
also send messages directly to the spinal cord triggering the nerves in the penis (Healthy 
Male, 2018d). 
Causes of erectile dysfunction 
There are various causes of ED, but it is commonly caused by a combination of physical 
and psychological factors (Table 1). Most cases of ED have a physical cause, with an 
estimated 80% likely to be due to vascular disease caused by endothelial dysfunction6 
related problems (McMahon, 2019). As an erection requires good blood flow into the penis, 
males who have a medical condition associated with narrowing of blood vessels, such as 
heart disease, stroke, high blood pressure and diabetes, have a greater risk of having 
erection problems (Healthy Male, 2018d). 
Table 1: Causes of erectile dysfunction 
Type of causal factor Examples 
Psychological Performance anxiety, depression, relationship 
problems, social or cultural factors, taboo, 
previous traumatic sexual experience 
Vascular Atherosclerosis, venous leakage 
Endocrine and metabolic conditions 
and other factors affecting blood 
vessel function 
Diabetes mellitus, hypertension, obesity, end-
stage renal failure, thyroid disease, 
hypogonadism (low testosterone), cigarette 
smoking 
Neurological Spinal cord injury, multiple sclerosis, pelvic 
surgery (prostate, bowel), Parkinson's disease 
Urological Peyronie's disease, pelvic or genital trauma or 
radiotherapy 
Medicines, drugs, alcohol Alcohol and drug abuse; SSRI 
antidepressants; some medications for 
hypertension, high cholesterol, prostate 
cancer. 
Sources: Adapted from Heathy Male, 2018 (Healthy Male, 2018d); McMahon, 2019 (McMahon, 2019) 
  
 
6  Endothelial dysfunction: the endothelium lines the blood vessels and has a role in vasodilation (expansion 
of blood vessels) and contraction of blood vessels. Alterations of endothelial physiology (endothelial 
dysfunction) is an early step in the development of atherosclerosis (where plaque or fatty deposits build up 
in the arteries). It is characterised by a reduction in chemicals that help to dilate blood vessels 
(vasodilators), particularly nitric oxide, and/or an increase in contracting factors from the endothelium, 
leading to less dilation of the blood vessels. 
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Prevalence of erectile dysfunction  
Details of the Australian studies that have estimated the prevalence of ED are given in 
Appendix 2. Studies have included men of varying age ranges and used different definitions 
of ED, but all showed that ED affects a significant proportion of males across age-groups, 
and that prevalence increases significantly with age (M. J. Adams et al., 2013; Banks et 
al., 2013; K. K. Chew, Stuckey, Bremner, Earle, & Jamrozik, 2008; Holden et al., 2005; S. 
Martin et al., 2012; Schlichthorst, Sanci, & Hocking, 2016; Weber et al., 2013; Wen, Rissel, 
Cheng, Richters, & de Visser, 2017). 
Of the Australian studies, only Adams’ 2004-2007 study reported the prevalence of ED 
specifically among Aboriginal and Torres Strait Islander males (M. J. Adams et al., 2013). 
In this study of males aged 18 to 74 years in communities across the Northern Territory 
(NT) and Queensland (Qld) (n=293), 16% of participants reported mild or mild-to-moderate 
ED and 14% reported moderate-to-severe ED, with increased prevalence across age 
groups. Notably, moderate-to-severe ED was reported by around 10% of younger 
Aboriginal and Torres Strait Islander males (in both the 18-24 and 25-34 years age-groups). 
Low testosterone (androgen deficiency) 
Low testosterone occurs when a man is not able to produce enough testosterone for his 
body to function normally. It is defined as a lower-than-normal serum testosterone level 
(normal range is about 8 nmol/L to 27 nmol/L but levels may vary according to the 
laboratory assay used) (Healthy Male, 2018a; Yeap et al., 2016a). 
Androgen deficiency is diagnosed when a male with symptoms of androgen deficiency 
has low serum testosterone (as described above) in two samples collected in the morning 
on separate days. Other hormones are tested to see if the cause of the androgen deficiency 
is a problem in the male's testes or his pituitary gland (a gland located at the base of the 
brain that controls the production of testosterone by the testes) (Healthy Male, 2018a). 
Knowing the cause of the problem helps to determine the best treatment. 
Androgens and testosterone in males 
Androgens, the predominant sex hormones in males, are involved with the development 
and maintenance of masculine characteristics in reproductive tissues, including the male 
reproductive tract, secondary sexual characteristics (such as body hair and facial hair) and 
fertility. Androgens also have a role in building and maintaining muscle and bone 
(Handelsman, 2020; Healthy Male, 2018a). 
Testosterone is the main androgen in males. Most testosterone is produced in the 
testes, with a small amount produced by the adrenal glands. Testosterone stimulates 
sperm production in the testes. At puberty, testosterone is needed for the changes that 
happen when a boy develops adult male characteristics and becomes able to reproduce. 
Testosterone also affects mood and libido (sex drive) and influences overall health and 
wellbeing (Grossmann, 2019). 
In general, circulating testosterone levels tend to peak in early adulthood and decline 
gradually across middle- and older-age (Yeap et al., 2019). 
Causes of androgen deficiency 
Testosterone levels decline slowly as men age, although it is probably due to chronic 
disease co-morbidities rather than age per se (Sartorius et al., 2012). For men with 
suspected androgen deficiency, particularly older men, it is important to assess if low 
testosterone is due to organic causes such as problems in the testes or the pituitary gland 
(pathological hypogonadism), which is likely to be irreversible and need to be treated with 
testosterone. If the low testosterone is not pathological but is due to the presence of obesity 
or chronic disease (functional hypogonadism), it may be helped with lifestyle changes 
(Grossmann, 2019). Understanding the cause will determine the best treatment and identify 
any underlying health conditions that may need treatment. 
Pathological causes include conditions affecting the hypothalamic-pituitary-testicular 
(HPT) axis, with complete hypogonadism affecting the production of both testosterone and 
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sperm, leading to androgen deficiency and infertility (Grossmann, 2019; Yeap et al., 
2016a). Klinefelter syndrome7 and pituitary tumours are common causes. Although 
Klinefelter syndrome is a chromosomal condition present at birth, it is often not diagnosed 
until adulthood or later, if at all (estimates suggest fewer than 50% of men with Klinefelter 
syndrome are diagnosed in their lifetime), thereby many men miss out on the benefits of 
intervention and testosterone treatment (Herlihy, Halliday, Cock, & McLachlan, 2011). 
Functional hypogonadism is more likely to affect older men who are overweight or 
obese and have chronic conditions such as diabetes, CHD, liver or kidney disease. In these 
cases, symptoms may be non-specific and overlap with the symptoms of such chronic 
diseases (Grossmann, 2019; Yeap et al., 2016a). Low testosterone levels in ageing men 
may be a consequence of potentially reversible effects on the HPT axis due to obesity, 
chronic disease or medication use, such that weight loss and management of chronic 
conditions may lead to increased testosterone levels (Grossmann, 2019; Grossmann & 
Matsumoto, 2017; Yeap et al., 2016a). Obesity is consistently associated with lower 
circulating testosterone levels and declining testosterone levels over time in longitudinal 
studies (Grossmann, 2019; Grossmann & Matsumoto, 2017; Yeap et al., 2016a). 
Conversely, studies of weight loss in obese men have demonstrated that the increase in 
testosterone is proportional to the amount of weight lost (Grossmann & Matsumoto, 2017). 
Prevalence of androgen deficiency 
Between 2% and 10% of middle-aged and older men are estimated to have androgen 
deficiency due to organic causes; however, there is likely to be widespread under-
diagnosis. Up to 1 in 10 older men have low testosterone, commonly in association with 
obesity and chronic disease (Healthy Male, 2018a; Wu et al., 2010). There are no published 
data on the prevalence of androgen deficiency among Aboriginal and Torres Strait Islander 
males specifically. 
Symptoms of androgen deficiency 
The symptoms of androgen deficiency are listed in Table 2 according to stage of life. The 
variety of presenting symptoms and the fact that many are non-specific mean that androgen 
deficiency can be difficult to diagnose. 
Erectile dysfunction and cardiovascular disease 
The significance of the association between ED and CVD has been gaining increasing 
recognition over the past 15 to 20 years. ED is not only a consequence of CVD, but may 
also predict the development of CVD in apparently healthy males (Araujo et al., 2010; 
Banks et al., 2013; K. Chew et al., 2010; Chiles, 2016; Gandaglia et al., 2014; Hackett & 
Kirby, 2018; Hackett, Krychman, et al., 2016; Holden, McLachlan, et al., 2010; Inman et al., 
2009; Jackson, 2013; Katsiki, Wierzbicki, & Mikhailidis, 2015; Miner et al., 2019; Nehra et 
al., 2012; Pastuszak et al., 2015; Raheem, Su, Wilson, & Hsieh, 2016; Thompson et al., 
2005; Uddin et al., 2018; Yao et al., 2018; Zhao et al., 2019) and those with diabetes 
(Gandaglia et al., 2014; Goldstein, Chambers, Tang, Stecher, & Hassan, 2018; Hackett, 
Krychman, et al., 2016; Yamada, Hara, Umematsu, Suzuki, & Kadowaki, 2012). ED may 
indicate undiagnosed or silent CVD (Miner et al., 2019; Osondu et al., 2018), and has been 
described as the 'canary in the coalmine' or the 'harbinger' of CVD. 
There is ongoing research into why endothelial dysfunction in blood vessels of the 
penis may happen earlier than in blood vessels in other areas of the body, such as the 
heart or the brain (Musicki et al., 2015). There are still many questions about mechanisms, 
but the evidence to date supports clinical observations that ED often occurs earlier than 
CVD (Musicki et al., 2015). In fact, it is thought that ED can occur about three to five years 
earlier than a CVD event (Jackson, 2013; Raheem et al., 2016), providing an opportunity 
 
7  Klinefelter Syndrome, also known as 47,XXY, is a genetic condition where a male is born with an extra X 
chromosome. Males with Klinefelter syndrome have small testes, are almost always infertile, and can have 
other physical characteristics such as breast development and little facial or body hair. 
 
9
Collins et al.: Male sexual health, CVD and T2DM in Aboriginal and Torres Strait Islanders
Published by Edith Cowan University, 2021
 
 
to not only improve erectile function but also to manage CVD risk (Holden, Allan, et al., 
2010). Based on this, clinical guidelines for the treatment of ED generally agree that a 
cardiovascular assessment should be undertaken to detect undiagnosed CVD or CVD risk 
factors when a male presents with ED (Burnett et al., 2018; Hackett et al., 2018; McMahon, 
2019; Miner et al., 2019; Nehra et al., 2012; Salonia et al., 2020; Shoshany et al., 2017). 
However, it is still debated as to whether a diagnosis of ED adds to CVD risk estimations 
based on conventional CVD risk factors, such as the Framingham risk score (Araujo et al., 
2010; Shah et al., 2016). 
Appendix 2 provides a summary of the extensive evidence of the links between ED 
and CVD, from both cross-sectional and longitudinal studies in Australian and overseas 
(mostly European) populations.  
The only study in Aboriginal and Torres Strait Islander males showed a strong cross-
sectional association between moderate-to-severe ED and self-reported diabetes, heart 
Table 2: Symptoms of androgen deficiency 
Stage of life Possible symptoms 
Early childhood Micropenis (penis does not grow to expected size) 
Small testes 
Early teenage years 
(puberty) 
Late puberty or failure to go through full normal puberty 
Small testes and penis 
Poor development of facial, body or pubic hair 
Poor muscle development 
Voice does not deepen (larynx underdeveloped) 
Gynaecomastia (breast development) 
Poor growth surge (height) 
Adulthood 
Mood changes (low mood and irritability) 
Poor concentration 
Low energy (lethargy, low stamina) 
Reduced muscle strength 
Increased body fat 
Decreased libido (low interest in sex) 
Difficulty getting and keeping erections (uncommon) 
Low semen volume 
Reduced facial or body hair growth  
Gynaecomastia (breast development) 
Hot flushes, sweats 
Osteoporosis (thinning of bones) 
Later life  
Mood changes (low mood and irritability) 
Poor concentration 
Easily fatigued 
Poor muscle strength 
Increased body fat 
Decreased libido (low interest in sex) 
Difficulty getting and keeping erections 
Gynaecomastia (breast development) 
Osteoporosis (thinning of bones) 
Source: Healthy Male, 2019 (Healthy Male, 2018a) 
More information on these and other male sexual and reproductive health conditions 
can be found on the Healthy Male website (www.healthymale.org.au).  
 
10




disease and high blood pressure (M. J. Adams et al., 2013). Although further evidence of 
the link between ED and CVD in Aboriginal and Torres Strait Islander males is not yet 
available, the risk factors for ED that also increase the risk of CVD, including smoking, 
alcohol, and high cholesterol levels, are common among Aboriginal and Torres Strait 
Islander males (Australian Indigenous HealthInfoNet, 2021). 
Links between ED and CVD in young males 
The strong association between ED and CVD in younger men identified in some studies 
(Banks et al., 2013; K. Chew et al., 2010; Fang, Rosen, Vita, Ganz, & Kupelian, 2015), is 
noteworthy (see the ‘Erectile dysfunction and cardiovascular disease’ section in Appendix 
2 for a summary of relevant studies). Although younger males have a lower chance of 
developing ED or CVD than older males, when a young male has ED it is more likely to 
indicate higher CVD risk (Yao et al., 2018). Moreover, there is evidence that ED in young 
adult males may signal other systemic health problems (Capogrosso, Montorsi, & Salonia, 
2016). This is a powerful message that has the potential to motivate young males to seek 
help when first experiencing ED, and for health professionals to broach the subject of ED, 
even with young adult males, so that they have the opportunity for early identification of 
CVD and potentially access effective treatments sooner. 
Erectile dysfunction, type 2 diabetes and cardiovascular disease 
Prevalence and determinants of erectile dysfunction in males with diabetes 
Along with other sexual health problems, ED is a common complication of diabetes with 
prevalence about two to three times higher than in males without diabetes (Kouidrat et al., 
2017). The prevalence is again higher among males with T2DM than among those with 
type 1 diabetes. ED prevalence estimates from studies of men with diabetes around the 
world range from about 35% to 75%, with a meta-analysis of 145 studies showing an overall 
prevalence of 66% in men with T2DM and 38% in men with type 1 diabetes (Kouidrat et 
al., 2017). In men with diabetes, ED develops up to 10 to 15 years earlier than in men with 
no diabetes and the risk of ED increases with age: one estimate suggests up to 95% of 60 
to 70-year-old men with diabetes would develop ED (Kamenov, 2015; Kouidrat et al., 2017). 
The risk of ED in men with diabetes is related to the duration of diabetes, poor glucose 
control (particularly in younger men) and presence of other co-morbidities and diabetes 
complications (Kamenov, 2015). 
The cross-sectional Australian studies reviewed in Appendix 2 have demonstrated 
associations between ED and diabetes, as well as other CVD risk factors (Holden, 
McLachlan, et al., 2010; S. Martin et al., 2012; Weber et al., 2013). Furthermore, a 
prospective analysis of the FAMAS cohort (a study sample of South Australian men aged 
35-80 years at baseline) showed diabetes to be predictive of ED incidence over five years, 
independent of other factors predictive of ED (such as higher age, lower income, higher 
abdominal fat mass, low alcohol intake, higher risk of obstructive sleep apnoea, voiding 
lower urinary tract symptoms and depression) in fully adjusted statistical models (S. A. 
Martin et al., 2014). 
The causes of ED in men with diabetes are more complex than in men without diabetes 
(Hackett, Krychman, et al., 2016). The process of endothelial dysfunction is accelerated in 
diabetes, leading to reduced blood flow to the penis (among other effects), making an 
erection more difficult. Endothelial dysfunction also leads to atherosclerosis and 
cardiovascular disease (Hackett, Krychman, et al., 2016). Diabetes can cause a reduction 
in a chemical produced in the body that is needed for the penis to remain erect (cyclic 
guanosine monophosphate) and nerves in the penis can be affected (Hackett, Krychman, 
et al., 2016). T2DM is often associated with lower circulating testosterone levels that can 
increase the risk of ED (Gianatti & Grossman, 2019; Hamilton et al., 2016). 
Undiagnosed diabetes in males with erectile dysfunction 
ED can be an indicator for undiagnosed diabetes. A recent review suggests between 5% 
and 12% of men with ED have undiagnosed diabetes (McMahon, 2019), although earlier 
studies suggest the prevalence of undiagnosed diabetes may be even higher in men with 
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ED (Kouidrat et al., 2017). A study of men aged 20 years or older in the United States of 
America (USA), found 12% of the men with ED had undiagnosed diabetes compared with 
2.8% of men without ED, with the difference most pronounced in those aged 40-59 years 
(19% vs 3.3%) (Skeldon, Detsky, Goldenberg, & Law, 2015). The association between ED 
and undiagnosed diabetes remained after adjustment for traditional CVD risk factors (odds 
ratio (OR)=2.2) (Skeldon et al., 2015). In an Italian study of 934 men presenting with ED to 
an andrology unit, of those with a diagnosis of diabetes (n=182), 19% were diagnosed with 
ED and diabetes at the same time and 13% had been diagnosed with ED before the 
diabetes was diagnosed (Mazzilli et al., 2015). 
Erectile dysfunction and risk of CVD in males with diabetes 
At the same time as the hypothesis that ED is a risk marker of CVD in men in the general 
population was drawing attention, men with diabetes were studied specifically, given their 
higher risk of ED and CVD, albeit not as extensively. A cross-sectional study of men with 
uncomplicated T2DM (published in 2004) showed that ED was the risk factor most strongly 
associated with silent CAD (along with other known CVD risk factors, including smoking 
and high cholesterol levels) (Gazzaruso et al., 2004). Thus, the presence of ED in men with 
uncomplicated T2DM should be a prompt to screen for CAD (Gazzaruso et al., 2004). 
In a study (published in 2010) of 6,304 men aged 55 to 88 years with T2DM, those 
with ED at baseline had elevated risks of developing any CVD (HR8=1.2), CHD (HR=1.4) 
and cerebrovascular disease (HR=1.4) over five years, independent of other CVD risk 
factors, when compared to men without ED (Batty et al., 2010). Meta-analyses of this and 
other studies showed the odds ratios for men with ED compared to those without were 1.7 
for all CVD and 1.7 for CHD (Yamada et al., 2012), stressing the importance of assessing 
erectile function in men with diabetes, not only because of the effect of ED on quality of life, 
but also as a marker of silent or future CVD (Yamada et al., 2012). 
Testosterone and cardiovascular disease 
Assessing the relationship between testosterone and CVD is complicated by the fact that 
age and obesity are risk factors for both CVD and low circulating testosterone levels. Age 
and obesity are also risk factors for T2DM, and men with diabetes are more likely to have 
low testosterone and are at higher risk of CVD (Grossmann, 2019; Yeap et al., 2019). 
Longitudinal studies have attempted to assess the effects of low testosterone on CVD while 
accounting for possible confounding by age and obesity, and these are reviewed in 
Appendix 2. 
When considering the links between testosterone levels and CVD, it is important to 
distinguish between low testosterone (or androgen deficiency) due to pathological causes, 
and low testosterone associated with ageing or chronic health conditions (functional 
hypogonadism). It is generally accepted that males diagnosed with androgen deficiency of 
a pathological cause (due to disorders of the hypothalamus, pituitary or testes) should 
receive testosterone treatment to relieve the symptoms of androgen deficiency and 
improve body composition (Yeap et al., 2016a), with the benefits of treatment outweighing 
any possible CVD risks of the treatment (Yeap et al., 2019). For this review, the focus is on 
low circulating testosterone levels in middle-aged and older men with functional 
hypogonadism, in whom treatment with testosterone is not usually recommended; in fact, 
the benefits and risks of testosterone treatment in this context are currently the subject of 
debate (Grossmann, 2019; Yeap et al., 2016a). 
Low testosterone, cardiovascular disease outcomes and death from CVD or any cause 
Study findings have been mixed but overall, there is support for an association between 
testosterone and CVD as well as death from any cause; however, there is not a consistent 
association with death due to CVD (Yeap, 2018; Yeap et al., 2019; Yeap et al., 2021). 
 
8  HR = hazard ratio. This gives an estimate of the increased risk of developing CVD in men with ED 
compared to those without ED. For example, HR=1.2 means that men with ED had 1.2 times the chance of 
developing CVD compared to men without ED. 
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Associations with CVD may be linear, with lower testosterone linked to higher risk of CVD, 
or U-shaped, where both abnormally low and high levels of testosterone are associated 
with CVD or death from any cause (Yeap, 2018; Yeap et al., 2019). In fact, findings from a 
Western Australian (WA) study suggest there may be an optimal range of testosterone, 
with both low and high testosterone associated with a higher risk of death from any cause 
(Yeap et al., 2014). However, with respect to death due to IHD specifically, only low 
testosterone levels were associated, suggesting that testosterone may have a protective 
effect on the heart, although again this is far from conclusive (Yeap et al., 2014). 
It is not yet clear whether testosterone levels are an independent risk factor for CVD 
or a marker of the presence of CVD or other systemic illness (Meyer & Wittert, 2018). 
However, if low testosterone is a consequence of obesity and lifestyle factors, losing weight 
and exercising can improve testosterone levels and reduce CVD risk (Meyer & Wittert, 
2018; Yeap, 2018; Yeap et al., 2019). 
Testosterone and type 2 diabetes 
It has long been known that lowered testosterone levels are common in men with T2DM, 
particularly those who have had the disease for a long period or have complications (Gianatti 
& Grossman, 2019). It is estimated that between 25% and 50% of men with T2DM have low 
testosterone (Gianatti & Grossman, 2019). Two Australian studies assessed the prevalence 
of low testosterone in men with diabetes (Grossmann et al., 2008; Hamilton et al., 2016). A 
cross-sectional study of a clinic-based population of 580 obese, elderly men with T2DM in 
Melbourne, Victoria (recruited in 2004-2005) showed 43% had low total testosterone levels 
with serum testosterone inversely related to age and body mass index (BMI) (Grossmann et 
al., 2008). In a prospective community-based study of 788 males from WA with diabetes 
(mean age of 66 years; recruited in 2008-2011), just under 30% had a total testosterone level 
lower than 10 nmol/L (Hamilton et al., 2016) (normal 8-27 nmol/L). In this study, low 
testosterone was independently associated with increased waist circumference and serum 
triglycerides, decreased total serum cholesterol, kidney disease and insulin therapy 
(Hamilton et al., 2016). A meta-analysis of 20 cross-sectional studies showed that males with 
diabetes had lower average total testosterone level than males without diabetes, with an 
estimated mean difference of -2.7 nmol/L (Ding, Song, Malik, & Liu, 2006). 
Longitudinal studies demonstrate a higher risk of developing T2DM in males with low 
testosterone, suggesting that testosterone may have a protective role with respect to 
developing T2DM (Ding et al., 2006; Gianatti & Grossman, 2019; Gyawali et al., 2018; 
Hackett & Kirby, 2018). An Australian study of 1,597 community-dwelling men aged 35 to 
80 years from South Australia (SA) (initially recruited in 2002-2006) found that baseline 
testosterone in men without T2DM was inversely associated with developing T2DM over a 
five-year follow-up (Gyawali et al., 2018). The association was independent of established 
diabetes risk factors and other related sex hormones (Gyawali et al., 2018). 
Insulin resistance is thought to be the mediating factor in lowered testosterone and 
diabetes (Gianatti & Grossman, 2019; Grossmann et al., 2008). Data suggest the 
relationship between insulin resistance and low testosterone operates in both directions, 
such that males with low testosterone have a higher risk of developing T2DM or metabolic 
syndrome and males with metabolic syndrome or T2DM have a higher risk of developing 
low testosterone (Ding et al., 2006; Gianatti & Grossman, 2019). 
Associations between low testosterone, type 2 diabetes and death  
Two Australian studies of men with T2DM have investigated links between testosterone 
and death, with conflicting results (Hamilton et al., 2016; Tint et al., 2016). In the Melbourne 
clinic-based study described in the previous section, 531 men with T2DM were followed for 
a mean 7.6 years during which time 33% died (Tint et al., 2016). Associations with death 
were identified for lower calculated free testosterone9 and higher sex hormone binding 
 
9  Free testosterone is the part of total testosterone that is not bound to any other chemical in the blood. It 
makes up a small proportion of total testosterone as a large proportion of total testosterone is bound to 
other hormones such as sex hormone binding globulin (SHBG). 
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globulin (SHBG; a sex hormone), independent of other risk factors. However, associations 
between low total testosterone and death lost statistical significance after adjustment for a 
range of other factors related to T2DM, including a measure of insulin resistance (Tint et 
al., 2016). These findings suggest that studies of total testosterone levels in men with 
diabetes may be confounded by the effect of insulin resistance and obesity on SHBG, that 
is in turn strongly correlated with total testosterone (Tint et al., 2016). 
In contrast to the findings from the Melbourne clinic study, 788 community-dwelling men 
with T2DM from the WA study (described in the previous section) were followed for a mean 
of 4.0 years (Hamilton et al., 2016). A U-shaped relationship between total serum 
testosterone quintiles10 and dying from any cause was found. Men in the second, third and 
fourth quintiles had lower death rates compared to the first (lowest) quintile of total 
testosterone, while those in the highest quintile had a higher risk of dying compared to the 
lowest quintile (Hamilton et al., 2016). However, there was no association with free 
testosterone or SHBG. The same pattern was observed for deaths due to CVD, although 
there were relatively few CVD deaths and once adjusted for other risk factors the association 
was not statistically significant (Hamilton et al., 2016). 
Extent of cardiovascular disease and diabetes among Aboriginal and 
Torres Strait Islander males  
The measures used here to describe the extent of CVD and diabetes among Aboriginal 
and Torres Strait Islander males include: 




It is important to note that some data presented here are derived from the National 
Aboriginal and Torres Strait Islander Health Survey (NATSIHS) 2018-19 (Australian Bureau 
of Statistics, 2019). Data from this survey were generally self-reported and not collected in a 
clinical setting. Moreover, data about people under the age of 15 years were generally 
reported by a parent or guardian. 
Where possible, data are presented disaggregated by sex to give an overview of male 
health specifically. However, in some cases sex-specific data is not available and overall 
figures are presented.   
Cardiovascular disease 
Broadly speaking, CVD refers to all conditions that affect the heart and blood vessels, 
including but not limited to: ischemic heart disease; cerebrovascular disease (including 
stroke); hypertension (high blood pressure); pulmonary heart disease and diseases of 
pulmonary circulation; diseases of the arteries, arterioles and capillaries; some diseases of 
the veins, lymphatic vessels and lymph nodes; acute rheumatic fever and rheumatic heart 
disease. The ABS and AIHW generally refer to the WHO International Statistical 
Classification of Diseases and Related Health Problems (ICD) for classifying conditions 
reported in their data collections (World Health Organization, 2016). Please refer to ICD-
10-CM codes (I00 – I99) for the full list of conditions that fall under the description of CVD. 
A narrower definition of ‘Heart, stroke and vascular disease’ is used in some data 
collections, this includes specifically: IHD (including heart attack and angina); 
cerebrovascular disease (including stroke); heart failure; oedema (fluid retention); and 
diseases of arteries, arterioles and capillaries.  
 
10  Quintiles of testosterone are when the distribution of testosterone levels in the study population are 
grouped into five categories such that each quintile category includes 20% of the males in the study. 
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CVD is a major contributor to the total (fatal and non-fatal) burden of disease in 
Aboriginal and Torres Strait Islander people and the health gap between Indigenous and non-
Indigenous Australians (Australian Institute of Health and Welfare, 2016b; Merone et al., 
2019). In the 2018-19 NATSIHS, 14% of Aboriginal and Torres Strait Islander males reported 
having CVD (Australian Bureau of Statistics, 2019). This included 5.5% of specifically 'heart, 
stroke and vascular disease' (as described above). When age-standardised, the rate was 
9.4% and more than double the rate among other Australians (4.7%) (Australian Bureau of 
Statistics, 2019). Prevalence of CVD among all Aboriginal and Torres Strait Islander people 
increased with age (see Table 3). 
Table 3. Prevalence of self-reported CVD among Aboriginal and Torres Strait Islander 
people, 2018-19  








Source: ABS, 2018-19 NATSIHS (Australian Bureau of Statistics, 2019)  
Hypertension (high blood pressure) was self-reported by 8.2% of Aboriginal and Torres 
Strait Islander males in the 2018-19 NATSIHS (Australian Bureau of Statistics, 2019). 
However, when blood pressure was measured hypertension was present in 25% of adult 
males. The prevalence of measured hypertension generally increased with age, although 
was highest among males in the 45-54 years age group at 40%.  
Hospitalisation data for Aboriginal and Torres Strait Islander males was presented in 
the Aboriginal and Torres Strait Islander Health Performance Framework Summary Report 
for the two-year period 2015-17. In this period, there were 14,696 hospitalisations of 
Aboriginal and Torres Strait Islander males with a principal diagnosis of ‘diseases of the 
circulatory system’11, a rate of 18 per 1,000 (Australian Institute of Health and Welfare & 
National Indigenous Australians Agency, 2020). Of these hospitalisations, IHD (including 
acute and subsequent myocardial infarctions) was responsible for 40%, followed by 
pulmonary and other forms of heart disease (32%), other/unspecified diseases of the 
circulatory system (14%), cerebrovascular diseases (8.3%), acute rheumatic fever (2.5%), 
hypertension (2.1%) and rheumatic heart diseases (1.1%) (Australian Institute of Health 
and Welfare & National Indigenous Australians Agency, 2020). Please see Appendix 1 for 
limitations around hospitalisation data.  
In 2019, IHD was the leading cause of death for Aboriginal and Torres Strait Islander 
males (Australian Bureau of Statistics, 2020). In New South Wales (NSW), Qld, WA, SA and 
the Northern Territory (NT) combined, there were 257 deaths due to IHD, an age-
standardised rate of 145 per 100,000 population. As expected, death rates due to IHD 
increased with age. Concerningly however, although rates were highest among older people, 
IHD is recognised as having a substantial impact on younger Aboriginal and Torres Strait 
Islander males; in 2015-2019, IHD was the leading cause of death for males aged 35-44 
years at a rate of 71 per 100,000, and the fourth-leading cause of death for those aged 25-
34 years at rate of 15 per 100,000 (Australian Bureau of Statistics, 2020). 
 
11  ICD-10 codes I00-I99. 
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Diabetes among Aboriginal and Torres Strait Islander males  
Diabetes is recognised as one of the most important health problems currently facing 
Aboriginal and Torres Strait Islander people and can lead to life-threatening health 
complications (Australian Institute of Health and Welfare, 2015a). The most common form 
is T2DM which occurs at earlier ages for Aboriginal and Torres Strait Islander people than 
for non-Indigenous people, and is often undetected and untreated. Complications from 
diabetes may occur within months of diagnosis while others may develop over several 
years (Australian Institute of Health and Welfare, 2011).  
There are shared risk factors between male sexual health conditions and diabetes. 
Aboriginal and Torres Strait Islander people with diabetes tend to have high levels of risk 
factors such as smoking and obesity (Australian Institute of Health and Welfare, 2016a, 
2020c), and may show signs of other chronic conditions, including chronic kidney disease, 
CVD, liver disease and anaemia (Australian Bureau of Statistics, 2014). T2DM is more 
often linked to ED and low testosterone, although males with type 1 diabetes may also 
suffer sexual health complications. 
The most recent data available for the prevalence of diabetes among Aboriginal and 
Torres Strait Islander people was collected for the 2018-19 NATSIHS. In this health survey 
7.6% of (or 31,770) Aboriginal and Torres Strait Islander males (all ages) reported having 
diabetes (all types) (Australian Bureau of Statistics, 2019; Australian Institute of Health and 
Welfare & National Indigenous Australians Agency, 2020). The prevalence of diabetes 
reported was similar between Aboriginal males and Torres Strait Islander males. When 
aged standardised12, the prevalence for Aboriginal and Torres Strait Islander males was 
13%, about 2.5 times higher than that for non-Indigenous males (4.9%)13.  
Data obtained in the 2018-19 NATSIHS were subjected to Detailed Microdata analysis 
by the ABS in 2019 which was used then to report on the prevalence of different types of 
diabetes. Microdata presented in the Indicators for the Australian National Diabetes 
Strategy 2016-2020: data update (2020) (Australian Institute of Health and Welfare, 
2020c), indicate the prevalence of T2DM was around 11% among Aboriginal and Torres 
Strait Islander adult males in 2018-19. The prevalence was shown to increase with age 
from 3% among those aged 18-44 years to 35% for those aged 65 years and over (see 
Table 4).  
Table 4. Prevalence of self-reported type 2 diabetes mellitus among Aboriginal and Torres 
Strait Islander adult males, 2018-19  
Age group (years) Number Proportion (%) 
18-44 4,583* 3.0 
45-54 6,849 18 
55-64 7,279 27 
65+ 6,382 35 
Total (18+) 25,093 11 
Source: AIHW (2020), based on ABS Detailed Microdata analysis of 2018-19 NATSIHS (Australian 
Institute of Health and Welfare, 2020c) 
Note: *Estimate should be used with caution. 
Hospitalisation is often required to treat the advanced stages or complications of 
diabetes (Australian Institute of Health and Welfare, 2015a). Hospital data can therefore 
provide some indication of the extent of diabetes in a population. However, several 
factors must be taken into account when interpreting hospital data: 
 
12  Proportions have been age standardised to the 2001 Australian Estimated Resident Population to account 
for differences in the age structure of the two populations. 
13  Non-Indigenous data are from the 2017-18 National Health Survey (NHS). 
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• the statistics relate to events of hospitalisation rather than to individual patients  
• there may be variation in the admission policies and reporting procedures for the 
management of diabetes across hospitals 
• those living in remote locations may not have access to hospitals 
• episode of diabetes are only reported when they are serious enough to require 
hospitalisation (Australian Institute of Health and Welfare, 2018, 2019a; 
Australian Institute of Health and Welfare & National Indigenous Australians 
Agency, 2020; Australian Institution of Health and Welfare, 2016). 
The most recent data about hospitalisations for T2DM among Aboriginal and Torres 
Strait Islander males were published in the Indicators for the Australian National Diabetes 
Strategy 2016-2020: data update (2020). In 2017-2018, there were 29,279 hospitalisations 
of Aboriginal and Torres Strait Islander males for T2DM, including 1,275 hospitalisations 
for T2DM as a principal diagnosis and 28,004 hospitalisations for T2DM as an additional 
diagnosis (Australian Institute of Health and Welfare, 2020c) (see Table 5). 
Table 5. Hospitalisations for type 2 diabetes mellitus among Aboriginal and Torres Strait 
Islander males, 2017-18  
 Number Rate (per 1,000 population) 
Principal diagnosis 1,275 3 
Additional diagnosis 28,004 68 
Principal and/or additional diagnosis 29,279 71 
Source: AIHW, 2020 (Australian Institute of Health and Welfare, 2020c) 
Note: T2DM was categorised as principal and/or additional diagnosis based on 10th edition ICD-10-
AM code E11 (World Health Organization, 2016). 
The Aboriginal and Torres Strait Islander Health Performance Framework Summary 
Report (2020) provides a comparison between Indigenous and non-Indigenous people 
hospitalised for a principal diagnosis of T2DM using rate ratios (Australian Institute of 
Health and Welfare & National Indigenous Australians Agency, 2020). When age 
standardised14, the rate of hospitalisations among Aboriginal and Torres Strait Islander 
males was 5.4 per 1,000 population, approximately four times higher than the rate for non-
Indigenous males.   
This disparity is also reflected in mortality rates for diabetes, where Aboriginal and 
Torres Strait Islander males are more than three times more likely to die from diabetes than 
their non-Indigenous counterparts (Australian Institute of Health and Welfare, 2020c). The 
rate of deaths15 from diabetes (all types) for Aboriginal and Torres Strait Islander males in 
2018 was 216 per 100,000 population, while for non-Indigenous males the rate was 68 per 
100,000 (Australian Institute of Health and Welfare, 2020c). 
In 2019, diabetes (all types) was the fifth leading cause of death among Aboriginal and 
Torres Strait Islander males in Australia16 (Australian Bureau of Statistics, 2020). The 
mortality rate increased with age and diabetes was listed in the top five causes of death in 
all age groups above 45 years. ‘Avoidable and preventable deaths’ refer to deaths that 
have arisen from a condition considered to be avoidable given timely and effective health 
care (Australian Institute of Health and Welfare, 2020c). AIHW analysis of the National 
Mortality Database indicate that in the five-year period 2014-2018, there were 408 
 
14  Rate ratios published by AIHW were calculated using ABS backcast population estimates and projections 
based on the 2016 Census. 
15  Includes data from NSW, Qld, WA, SA and the NT only. 
16  Includes data for NSW, Qld, WA, SA and the NT only. Data for other jurisdictions have been excluded in 
line with national reporting guidelines (Australian Bureau of Statistics, 2020). 
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‘avoidable and preventable deaths’ from diabetes (all types) among Indigenous 
Australians, at an age-standardised rate of 46 per 100,000 population.  
Risk factors for diabetes and cardiovascular disease among 
Aboriginal and Torres Strait Islander males  
Many of the risk factors for ED and low testosterone are also factors that increase the risk 
of CVD and T2DM. These include being overweight or obese and smoking tobacco, which 
are both relatively common among Aboriginal and Torres Strait Islander males (Australian 
Indigenous HealthInfoNet, 2021; Healthy Male, 2018d). Alcohol can also be a risk factor 
for sexual and chronic conditions. Aboriginal and Torres Strait Islander people are less 
likely to drink alcohol than other Australians, but those who do drink alcohol are more likely 
to do so at harmful levels (Australian Institute of Health and Welfare, 2017a, 2017b). 
Bodyweight 
One way of establishing if a person is overweight or obese is by calculating their Body 
Mass Index (BMI) using height and weight measurements. By calculating each participant’s 
BMI, the 2018-19 NATSIHS indicated that 71% of Aboriginal and Torres Strait Islander 
males aged 15 years and over were either overweight (31%) or obese (40%) (Australian 
Bureau of Statistics, 2019; Australian Institute of Health and Welfare, 2020c). However, it 
is important to note that the optimal BMI range is based on national standards and may not 
be accurate for Aboriginal and Torres Strait Islander males due to differences in body shape 
and other physiological factors (Daniel, Rowley, McDermott, & O'Dea, 2002; Gracey et al., 
2007; Li & McDermott, 2010). 
Alcohol and tobacco use 
The health impacts of alcohol and tobacco use, including increased risk of chronic diseases 
such as diabetes and CVD, have been well established (Australian Health Ministers' 
Advisory Council, 2017). Tobacco smoking reduces blood vessel function which is known 
to be a cause of ED, and alcohol too can be contributing factor. In the 2018-19 NATSIHS, 
42% of Aboriginal and Torres Strait Islander males aged 15 years and over reported they 
were current daily smokers (Australian Bureau of Statistics, 2019).  
The NATSIHS also reported that 65% of Aboriginal and Torres Strait Islander adult males 
reported exceeding the guideline (2009) (National Health and Medical Research Council, 2009) 
for drinking on a single occasion17 and 30% reported exceeding the lifetime risk18 guideline 
(Australian Bureau of Statistics, 2019). Aboriginal and Torres Strait Islander males were three 
times more likely to exceed the guideline for lifetime risk than females. 
Management and treatment 
ED and low testosterone can be both causes and consequences of CVD and T2DM. So, 
apart from the benefits to a male's sexual health from receiving treatment for a sexual 
health problem, there can be wider benefits to his general health. It would seem prudent 
therefore, that a man with CVD or T2DM, or at risk of these conditions, should have sexual 
health assessments as part of his general health care. 
The sexual health impacts of CVD and T2DM in Aboriginal and Torres Strait Islander 
males have not been well documented; however, the fact that CVD and T2DM are common 
among Aboriginal and Torres Strait Islander males would suggest that sexual problems are 
also likely to be common. The extent of assessment and management of sexual problems 
in Aboriginal and Torres Strait Islander males, whether a consequence of chronic disease 
 
17  Four or less standard drinks on a single day for both males and females (National Health and Medical 
Research Council, 2009). 
18  No more than two standard drinks on any single day (National Health and Medical Research Council, 
2009). 
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or not, is also not known. There are many barriers to discussions about sexual health, either 
in the community or in the healthcare context, which would suggest that many males with 
sexual health problems are not being assessed, diagnosed, or treated (M. Adams, 2014; 
M. J. Adams et al., 2013; Wenitong et al., 2014). 
The management and treatment of diabetes and CVD in Aboriginal and Torres Strait 
Islander people have been reviewed in earlier HealthInfoNet reviews (Burrow & Ride, 2016; 
Merone et al., 2019). Here, the focus is on current guidelines for assessment, management 
and treatment of ED and low testosterone, specifically in the context of CVD and T2DM. It 
should be noted that the guidance summarised here is general and not tailored to men of 
particular ethnicity or culture. However, where there are recommendations specific for 
Aboriginal and Torres Strait Islander males, they are included. 
Assessment and management of erectile dysfunction in the context of 
cardiovascular and disease type 2 diabetes 
Assessment of erectile dysfunction 
There are no Australian consensus practice guidelines for diagnosing and managing ED in 
general, or for Aboriginal and Torres Strait Islander males specifically. However, overseas 
guidelines and expert consensus (Burnett et al., 2018; Hackett et al., 2018; Nehra et al., 
2012; Salonia et al., 2020), as well as Australian clinical practice recommendations 
(Healthy Male, 2018b; McMahon, 2019; Shoshany et al., 2017), all include measurement 
of glucose levels (for diagnosis of diabetes or impaired glucose tolerance) and CVD risk as 
essential elements in the assessment of a male presenting with ED. 
The discussion of a male's sexual heath is most likely to happen in the context of 
primary care (Healthy Male, 2018b; Shoshany et al., 2017). Given that there are barriers 
to discussing sexual health problems for both males and health professionals, it's important 
for a health professional to take the initiative. The subject of sexual health needs to be and 
broached with a male patient in a sensitive and straightforward manner, taking into account 
his ethnic, cultural and personal background (Althof, Rosen, Perelman, & Rubio-Aurioles, 
2013; Shoshany et al., 2017). Health professionals can start the conversation about erectile 
problems with a normalising question so that the male feels he is not alone in having sexual 
problems, but that it is in fact quite common (Althof et al., 2013; Healthy Male, 2018b; 
Shoshany et al., 2017). For Aboriginal and Torres Strait Islander males in particular, it is 
important for the health professional to build trust with the male over a period of time, 
perhaps over several consultations, and to provide a safe, private and comfortable 
environment (Wenitong et al., 2014). 
Assessments of a male presenting with ED should include a full medical and culturally 
sensitive sexual history to confirm firstly that the man has ED, and then to determine the 
onset, severity and duration of the ED, whether he has any other sexual problems, and the 
impact of the ED on his psychological wellbeing and relationships (McMahon, 2019; 
Shoshany et al., 2017). A comprehensive medical history may reveal the likely cause of 
the ED, including certain medications and chronic conditions, but often the cause is not 
easily identified and may include physical as well as psychological factors. A physical 
examination should include a genital examination and a cardiovascular examination 
(Healthy Male, 2018b). 
Laboratory testing can be tailored to the male's age and other risk factors, but generally 
should include screening for diabetes (blood glucose), cholesterol and triglycerides levels, 
testosterone (for possible androgen deficiency), and possibly further testing for CVD, if 
indicated (Healthy Male, 2018b; McMahon, 2019; Shoshany et al., 2017). A psychosocial 
assessment should include an assessment of the male's general psychological wellbeing 
and effects on his relationship, and determine whether psychological factors are 
contributing to the ED (Healthy Male, 2018b; McMahon, 2019; Shoshany et al., 2017). 
Assessing a male with ED for depression may be useful as well as an inquiry about ED in 
males with depression. As some anti-depressants may cause ED or make it worse, a 
change of medication may be needed (Shoshany et al., 2017). 
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Erectile dysfunction and cardiovascular disease 
Clinical guidelines on managing ED generally agree that a man presenting with ED that is 
caused by physical factors should be assessed for risk or presence of CVD, due to the 
strong links between ED and CVD (Burnett et al., 2018; Hackett et al., 2018; McMahon, 
2019; Miner et al., 2019; Nehra et al., 2012; Salonia et al., 2020; Shoshany et al., 2017). 
The Princeton III consensus recommendations for the management of erectile dysfunction 
and cardiovascular disease state that any man with organic ED should be considered at 
risk for CVD until examinations and tests show otherwise (Nehra et al., 2012). There are 
no similar Australian consensus guidelines but one recent summary of international 
practice guidelines recommends a comprehensive assessment of CVD, amongst other 
recommendations for managing ED in the Australian context (McMahon, 2019). 
For men with existing CVD, ED is probably related to generalised vascular disease 
that contributes to both conditions simultaneously (Hackett et al., 2018). In men with CHD, 
psychological factors may also contribute to ED if they, and their partners, are afraid that 
intercourse could precipitate further coronary episodes (Hackett et al., 2018). An 
assessment of erectile function in men with CVD should therefore be part of their care. 
Erectile dysfunction and type 2 diabetes 
As ED may be the first sign of undiagnosed T2DM, a thorough assessment of a male with 
ED provides an opportunity to diagnose and treat T2DM as well as the ED. 
The Royal Australian College of General Practitioners Management of type 2 diabetes: 
a handbook for general practice gives no specific recommendations for assessing or 
managing ED in males with diabetes (The Royal Australian College of General 
Practitioners & Diabetes Australia, 2020). However, due to the higher risk of ED (and other 
sexual problems), increasing risk of ED with duration of disease and poor blood glucose 
control, and younger age of onset of ED, it would seem prudent for men with T2DM to have 
regular screening for ED. 
Aboriginal and Torres Strait Islander people with T2DM tend to have worse rates of 
complications and CVD risk profiles than non-Indigenous people (Davis et al., 2012). For 
males with T2DM, the risk of CVD is higher when ED is present; a diagnosis of ED in a 
male with diabetes is an opportunity to address both the sexual dysfunction as well as 
careful regular evaluation and management of CVD or CVD risk factors (Batty et al., 2010; 
Yamada et al., 2012). 
Treatment of erectile dysfunction 
Lifestyle modification and management of risk factors, such as smoking, alcohol intake, 
body weight, physical activity, hypertension and high cholesterol, as well as good 
management of any co-morbid conditions (particularly diabetes and CVD), should be 
considered before or with other treatments for ED (Hackett et al., 2018; Healthy Male, 
2018b; McMahon, 2019; Shoshany et al., 2017). Increased physical activity, weight loss, 
and optimal management of diabetes and CVD can probably help prevent and may improve 
ED (McMahon, 2019). If medications may be contributing to ED (see Hackett et al., 2016 
(Hackett, Krychman, et al., 2016)), a change of anti-hypertensive, antidepressant or other 
medication might be necessary, particularly if the male wants to be sexually active (Healthy 
Male, 2018b; Shoshany et al., 2017). If androgen deficiency is diagnosed and a cause 
established, this should be managed with testosterone therapy and may result in an 
improvement in erectile function (if it is due to the androgen deficiency) and sexual desire 
(Hackett et al., 2018; Healthy Male, 2018b; Yeap, 2018). This would involve consultation 
with an endocrinologist (Healthy Male, 2018b). 
For psychological problems, depression or relationship issues, psychosexual therapy 
may be warranted with a specialist counsellor, psychologist or in rare cases, a psychiatrist. 
Any sexual misinformation should be discussed with the male, and his partner if 
appropriate, including having realistic expectations of erectile function (for example, age-
related changes) and the need for sufficient arousal and lubrication (Healthy Male, 2018b; 
McMahon, 2019; Shoshany et al., 2017). 
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Treatments for ED range from non-invasive treatments to surgery (Table 4). The most 
commonly used treatment is an oral medication (belonging to a class of drug called PDE5 
inhibitors), of which there are various types, dosages, dosing regimens and side-effects 
(Healthy Male, 2018b; McMahon, 2019; Shoshany et al., 2017). The benefits and 
disadvantages of each type of medicine (including the cost) should be discussed with the 
male and the one most suited to his needs can be trialled first. Up to 65% of males will 
respond to oral medication and will be able to have sexual intercourse (McMahon, 2019). 
However, there are some contraindications, including if the male is taking short or long-
acting nitrate medication (most often used for angina), or the recreational use of amyl 
nitrate (sometimes known as ‘poppers’ or ‘liquid gold’) (Healthy Male, 2018b; McMahon, 
2019; Shoshany et al., 2017). 
If oral medications are not successful, or the patient has a preference to not take them, 
other treatments can be discussed (listed in Table 6) and referrals can be made to 
specialists as needed. 
Table 6: The main treatments for erectile dysfunction 
Non-invasive treatments 
Prescribed oral medication  
External devices: rubber rings, vacuum devices 
Injectable treatments Penile injections 
Surgery 
Penile prosthesis 
Vascular surgery (for select patients; not as 
effective for men with vascular disease (Trost, 
Munarriz, Wang, Morey, & Levine, 2016))  
Treatment of Peyronie’s disease 
Source: adapted from Healthy Male, 2018 (Healthy Male, 2018b) 
Treatment in males with cardiovascular disease 
Given that ED and CVD share the same risk factors, lifestyle interventions to reduce risk factor 
levels will have benefits for both CVD and sexual function. Moreover, the ED may be indicative 
of silent CVD and this could be uncovered through careful evaluation (McMahon, 2019). 
The risk to the heart from sexual activity is low in males with CVD, and most men can 
have normal sexual activity and use medications for ED (Hackett & Kirby, 2018; McMahon, 
2019). Guidelines on managing ED in males with CVD base recommendations for sexual 
activity on risk groups based on risk factors and diagnosed CVD (McMahon, 2019; Nehra 
et al., 2012). Only the highest-risk group is recommended not to undertake sexual activity 
until their CVD is stabilised (Nehra et al., 2012). In general, oral medication can be an 
effective and safe treatment for ED in males with CVD and there may even be some 
cardiovascular benefits from their use (Hackett & Kirby, 2018). 
Treatment in males with type 2 diabetes 
For males with T2DM, treatments for ED include the general lifestyle and risk factor 
reduction measures described above, specifically aiming to reduce body weight (if 
overweight), improve control of blood glucose levels and reduce high cholesterol and blood 
pressure (Kamenov, 2015). As males with T2DM are likely to be taking other medications, 
an evaluation of medication use should be done, although it is more likely that the ED is 
due to the diabetes rather than the medication (Hackett & Kirby, 2018). The first treatment 
is most likely an oral medication, although they are not quite as effective in males with 
T2DM or pre-diabetes compared to males without diabetes (Boeri et al., 2020; Kamenov, 
2015; Lue et al., 2015). 
Men with T2DM have a higher risk of low testosterone and if androgen deficiency is 
confirmed, testosterone treatment may be indicated (Lue et al., 2015), which could improve 
erectile function (Hackett, Cole, et al., 2016). Treatment of androgen deficiency may also 
improve the effectiveness of oral medication in males with diabetes (Hackett et al., 2018). 
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Assessment and management of low testosterone in the context of 
cardiovascular disease and type 2 diabetes 
Assessment of low testosterone 
The Endocrine Society of Australia Position statement on male hypogonadism (part 1): 
Assessment and indications for testosterone therapy (Yeap et al., 2016a) and the Healthy 
Male Clinical summary guide: Androgen deficiency diagnosis and management (Healthy 
Male, 2018a) provide guidance on the assessment of a male with suspected androgen 
deficiency. If a male presents with symptoms of androgen deficiency, it is important to 
determine if it is pathological or functional androgen deficiency (as defined above) 
(Grossmann, 2019; Healthy Male, 2018a; Yeap et al., 2016a). A comprehensive medical 
history, including information on smoking, medication use and recreational drug use 
(including androgens and other performance enhancing drugs and supplements) and 
history of pituitary disease. A review of the reproductive system is also required including 
pubertal development, fertility, erectile function, sexual desire and history of pelvic surgery 
or trauma or undescended testes (Yeap et al., 2016a). 
A physical examination should include a genital examination to check testicular volume; 
small testis volume is the defining feature of Klinefelter syndrome (described above and in 
the Glossary) (Healthy Male, 2018a; Yeap et al., 2016a). If androgen deficiency is suspected 
laboratory assessment of two morning fasting serum testosterone levels will confirm the 
diagnosis. Other hormone levels or other tests may be done to look for specific causes of 
pathological androgen deficiency (Healthy Male, 2018a; Yeap et al., 2016a). 
Low testosterone and cardiovascular disease 
Assessment of symptoms of low testosterone in males with CVD or CVD risk factors is 
prudent because of the associations between low testosterone and CVD (Yeap & Wu, 
2019). Usually, testosterone levels in these males will be at the lower end of the normal 
reference range, and management of CVD and obesity may improve the situation without 
the need for testosterone therapy (Grossmann & Matsumoto, 2017). However, if 
testosterone levels are very low, an assessment of causes should be done, in addition to 
managing the CVD (Grossmann & Matsumoto, 2017). 
Low testosterone and type 2 diabetes 
Given the higher risk of low testosterone associated with diabetes, it is recommended that 
males with T2DM should be asked routinely about symptoms of low testosterone (as well as 
ED) (Gianatti & Grossman, 2019). If symptoms of low testosterone are present, a serum 
testosterone measurement can be done. Males with T2DM and very low testosterone should 
be assessed for underlying pathological androgen deficiency (Gianatti & Grossman, 2019). 
Men without T2DM who have low testosterone level should have their blood glucose 
levels measured regularly given their increased risk for developing T2DM (Gianatti & 
Grossman, 2019). 
Treatment of low testosterone 
Indication for testosterone treatment is dependent on the results of the clinical assessment 
and laboratory testing (Yeap et al., 2016a). The aim is to restore testosterone to normal 
levels and alleviate the primary symptom of androgen deficiency (Grossmann & 
Matsumoto, 2017; Healthy Male, 2018a; Yeap et al., 2016b). In such males, treatment is 
likely to be life-long. There are some contraindications to testosterone treatment, including 
advanced prostate cancer (Healthy Male, 2018a; Yeap et al., 2016b). For males wishing to 
father children, possible effects on fertility and the option of sperm storage should be 
discussed before starting testosterone treatment (Yeap et al., 2016a). 
Monitoring of males undergoing testosterone treatment is essential (Healthy Male, 2018a; 
Yeap et al., 2016b). Follow-up tests may include testosterone levels, symptoms of low 
testosterone, PSA testing (guidelines as for other men, unless a known high risk of prostate 
cancer), CVD risk factors and bone density (Healthy Male, 2018a; Yeap et al., 2016b). 
In men with low testosterone but no diagnosis of pathological androgen deficiency, the 
low testosterone is usually a marker of other illnesses and testosterone treatment is not 
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generally recommended (Grossmann & Matsumoto, 2017; Healthy Male, 2018a; Yeap et al., 
2016a). At present, there is limited evidence that testosterone treatment would be beneficial 
in these males but treatment of the underlying conditions, in particular obesity, is warranted 
(Grossmann & Matsumoto, 2017; Yeap et al., 2016a). Weight loss and improvements in other 
chronic conditions have the potential to improve symptoms and increase testosterone levels 
(Grossmann, 2019; Grossmann & Matsumoto, 2017). 
In some middle-aged and older males, where other measures have not been 
successful, testosterone treatment may be trialled after counselling about the lack of 
evidence for the benefits and risks of testosterone treatment, and with careful monitoring 
for adverse events (Grossmann & Matsumoto, 2017). To obtain subsidised testosterone 
through the Pharmaceutical Benefits Scheme (PBS) for men aged 40 years or over, the 
testosterone level must be less than 6 nmol/L and a referral to a specialist is necessary 
(Healthy Male, 2018a). 
Treatment in males with cardiovascular disease 
Testosterone treatment in men with CVD and low testosterone should be approached with 
caution and careful monitoring, unless there is a clear pathological androgen deficiency 
(Grossmann, 2019; Yeap et al., 2019; Yeap et al., 2016b). Managing existing CVD or CVD 
risk factors, particularly obesity, is the recommended treatment approach for low testosterone 
in males with CVD (Grossmann, 2019; Yeap et al., 2019; Yeap et al., 2016b). 
Treatment in males with type 2 diabetes 
Testosterone treatment can reduce fat mass, increase muscle mass and improves insulin 
resistance, but randomised controlled trials do not show a consistent benefit to improved 
blood glucose levels (Gianatti & Grossman, 2019). Asymptomatic men with T2DM and low 
testosterone levels should be encouraged to lose weight and optimise blood glucose 
control rather than be offered testosterone treatment (Gianatti & Grossman, 2019; Yeap et 
al., 2016a). Treatment with standard anti-hyperglycaemic therapies can improve 
testosterone levels (Gianatti & Grossman, 2019). As for all males with low testosterone that 
is not pathological, if testosterone treatment is trialled, it should be closely monitored given 
the uncertainty of the benefits and risks of treatment (Gianatti & Grossman, 2019). 
Evidence for sexual health benefits from lifestyle modification 
There is an evidence base to support lifestyle modifications for ED and low testosterone. 
The focus has been on interventions similar to those used in CVD and T2DM prevention 
and treatment: diet, physical activity, weight loss and cessation of smoking. 
Interventions to improve erectile function 
A systematic review of six trials of exercise and/or dietary interventions aimed at weight loss, 
or treatment with cholesterol-lowering medications showed that improvements in CVD risk 
factors also led to modest improvements in erectile function (Gupta et al., 2011). Improvement 
in erectile function in men with diabetes may be less than for men without diabetes, possibly 
due to more vascular disease in men with diabetes (Gupta et al., 2011). Another review found 
smoking cessation improves erectile function (Hehemann & Kashanian, 2016). 
A small study of a Mediterranean diet showed benefits in men with ED and metabolic 
syndrome, and physical activity has been shown to improve erectile function (Hehemann 
& Kashanian, 2016). Weight loss of 5% to 10% in overweight or obese nondiabetic or 
diabetic males can result in improvement in erectile function over a short period of time 
(Maiorino, Bellastella, & Esposito, 2015). Studies of psychological interventions combined 
with ED medication showed a greater effect on improving ED than medication alone 
(Hehemann & Kashanian, 2016). 
A recent analysis of a very large follow-up study in the USA (21,469 men) showed that 
healthy diets were associated with a lower risk of developing ED, particularly in men under 
the age of 60 years (Bauer et al., 2020). The effect of diet was independent of BMI and 
physical activity (Bauer et al., 2020). 
The mechanisms by which weight loss, a healthy diet and physical activity can improve 
erectile function include improvements in endothelial dysfunction, insulin resistance and 
23
Collins et al.: Male sexual health, CVD and T2DM in Aboriginal and Torres Strait Islanders
Published by Edith Cowan University, 2021
 
 
alleviation of low-grade inflammation associated with diabetes and metabolic syndrome 
(Maiorino et al., 2015). 
Interventions to increase testosterone 
A recent large (n=208,677 males aged 40-69 years) study showed associations between 
lifestyle factors and medical conditions and low testosterone levels, providing support for 
modifying lifestyle and treating medical conditions to increase testosterone (Yeap et al., 
2021). There are few studies of lifestyle interventions to increase testosterone, but weight 
loss, whether by diet or surgery, can lead to increased testosterone levels that is 
proportional to the amount of weight lost: 10% weight loss increases testosterone by 2-3 
nmol/L; in morbidly obese men with a large amount of weight loss following surgery, 
testosterone can increase by 10 nmol/L (Corona et al., 2013; Grossmann & Matsumoto, 
2017; Yeap et al., 2016a). A systematic review and meta-analysis of 24 trials showed that 
the rise in testosterone was greater in those who lost more weight and in younger, non-
diabetic males with higher levels of obesity (Corona et al., 2013). 
Testosterone treatment may add to the benefits of lifestyle interventions in middle-
aged and older men (Wittert et al., 2021), and testosterone treatment may help motivate 
men to stick with diet and exercise programs due to increased energy levels (Grossmann 
& Matsumoto, 2017). However, as stated earlier, testosterone treatment in men with 
functional low testosterone is not recommended, except in specific clinical circumstances 
(Yeap et al., 2016b). 
Access to chronic disease and sexual health care in Aboriginal and Torres 
Strait Islander communities 
Guidelines and recommendations for assessment and management of male sexual health 
conditions and associated chronic diseases, can only be implemented if services and 
support are available and Aboriginal and Torres Strait Islander males are able and willing 
to access them. This requires: 
• awareness and knowledge of sexual health and the links with chronic disease 
among males and healthcare providers working with males 
• culturally appropriate male-specific primary healthcare services and healthcare 
providers 
• culturally safe spaces to discuss sensitive sexual health issues with the 
assurance of confidentiality 
• access to specialist health practitioners (e.g., endocrinologists, sex therapists) 
when needed 
• access to appropriate treatment 
• support for males undergoing treatment and healthy lifestyle interventions 
• capacity for ongoing monitoring of sexual health and the effects of treatment 
within primary healthcare services. 
There is a range of barriers to health service access or service delivery to Aboriginal 
and Torres Strait Islander males, including societal, cultural, logistical, health system, 
financial and individual factors (M. Adams, 2014; Arney & Westby, 2012; K.  Canuto, 
Brown, Wittert, & Harfield, 2018; K. Canuto, Wittert, Harfield, & Brown, 2018; Davy et al., 
2016; Wenitong et al., 2014). Some barriers are relevant to both males and females, while 
others apply specifically to males and have particular relevance to the sensitive area of 
sexual health (Table 7) (Arney & Westby, 2012; K.  Canuto et al., 2018; K. Canuto et al., 
2018; Wenitong et al., 2014). 
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Sex-specific differences in health 
Racism 
Cultural 
Traditional gender-related lore, masculinity, and gender roles 
Language barriers 
Beliefs about causation of illness (cursed by others, punishment for past 
wrongdoing) 
Logistical 
Lack of transport to services 
Conflict of appointment times and/or inflexible appointment times that do 
not allow for cultural and family priorities that can occur at short notice 
Health 
system 
Limited access to specialist services 
Complicated referral processes 
Lack of male health professionals 
Female health professionals not understanding male needs 
Medical terminology and jargon 
Perception services are geared to women and children, men can feel 
socially excluded 
Waiting times 
Culturally inappropriate service/undertrained staff 
Distrust/discrimination 
Inadequate or short-term funding for services; complex funding sources 
Financial Hard to meet health service or medication costs 
Individual 
Lack of knowledge or misinformed perception of illness 
Previous negative experience with healthcare 
Lack of knowledge of availability or purpose of local health services 
Low prioritisation of preventive healthcare 
Lack of understanding 
Low self-esteem/lack of confidence 
Feelings of shame/embarrassment 
Feelings of invincibility/a need to be strong 
Source: Adapted from (Wenitong et al., 2014), (M. Adams, 2014), (K. Canuto et al., 2018), (K.  
Canuto et al., 2018), (Davy et al., 2016) and (Arney & Westby, 2012) 
Attempts to increase male engagement with health services have often focused on 
changing the behaviour of men to engage with services. However, many of the barriers to 
access lie outside the individual, so a much broader approach is needed with a focus on 
how services are delivered and the cultural context of services for males (Arney & Westby, 
2012; Prehn & Ezzy, 2020), for management of sexual health problems. Males are 
motivated to engage with primary health services providing they feel safe and welcomed 
and have a rapport with staff (K. Canuto et al., 2018; Davy et al., 2016). 
Access to chronic disease management 
Despite the existence of many recommendations and guidelines for managing CVD and 
diabetes in Aboriginal and Torres Strait Islander people, barriers to healthcare for these 
conditions still exist (Burrow & Ride, 2016; Merone et al., 2019). These barriers need to be 
addressed to ensure Aboriginal and Torres Strait Islander people receive the optimal level 
of care. 
A systematic review of barriers and enablers to primary healthcare interventions for 
chronic diseases in Aboriginal and Torres Strait Islander people identified five categories 
of factors that can either inhibit or enable successful interventions: design attributes (such 
as community engagement, leadership, funding), the chronic disease workforce (such as 
level of training, exclusion of health workers from decision-making), patient-provider 
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partnerships (such as healthcare providers empowering patients to be partners in their own 
care), clinical care pathways (such as referral pathways for comprehensive care), and 
access (such as culturally safe practices and spaces) (Gibson et al., 2015). These factors 
are not fixed and can change from being barriers to enablers if addressed appropriately 
(Gibson et al., 2015). 
On the positive side, there are many programs and services designed to improve 
access and care for CVD and diabetes (Burrow & Ride, 2016; Merone et al., 2019). For 
example, Aboriginal Community Controlled Health Organisations (ACCHOs) reduce 
barriers by providing culturally appropriate services, including Aboriginal and Torres Strait 
Islander Health Workers and Practitioners (ATSIHWPs). There has also been a three-fold 
increase in uptake of annual health assessments (Medicare MBS item 715) between 2010-
11 and 2017-18, which suggests increased service use, although the uptake of health 
checks remains higher among females than males (Australian Institute of Health and 
Welfare, 2019b). A recently developed 'Wellbeing Framework' provides practical guidance 
for primary healthcare to develop chronic disease services that are appropriate for local 
communities, whether they be urban, rural or remote (Davy C.  et al., 2017). A feature of 
the Framework is its flexibility, allowing services to be designed to respond to individual 
and community health needs while upholding the specific cultural and social priorities for 
the community (Davy C.  et al., 2017). 
Access to medicines 
The level of access to treatments for ED and testosterone treatment in Aboriginal and Torres 
Strait Islander communities has not been documented and access is likely to vary between 
remote, rural and urban communities. After addressing ED risk factors such as diabetes 
management, oral medications are the main treatment for ED. There are costs associated 
with these medications (PDE5 inhibitors), which are not covered by a PBS subsidy for most 
men, as well as a possible stigma attached to using such treatments (M. Adams, 2014). 
Similarly, testosterone treatment may not be readily available in some communities and may 
require access to a specialist endocrinologist, at least when treatment is being started. 
Certain conditions have to be met before testosterone is covered by the PBS, including the 
involvement of a specialist (McLachlan, 2015); otherwise the costs of testosterone are 
substantially higher. 
Engaging Aboriginal and Torres Strait Islander males with care and 
services for sexual health 
A substantial proportion of men in the general Australian community are not seeking or 
receiving help for sexual health problems, for various reasons that include individual and 
health service factors (K. K. Chew et al., 2008; Holden et al., 2006; Holden et al., 2005; 
Schlichthorst et al., 2016), suggesting that this is a community-wide problem. However, 
specific and often more complex barriers exist for Aboriginal and Torres Strait Islander 
males to seeking and receiving healthcare in general, or for sexual health problems in 
particular (M. Adams, 2014; Arney & Westby, 2012; K.  Canuto et al., 2018; K. Canuto et 
al., 2018; Davy et al., 2016; Wenitong et al., 2014). There are no published studies 
describing the implementation and effectiveness of strategies to increase primary 
healthcare use by Aboriginal and Torres Strait Islander males (K.  Canuto et al., 2018). 
Involving males from the local community in the design or re-configuration of health 
services would be a positive first step to providing more culturally appropriate services that 
cater to the needs of the males in the community (Arney & Westby, 2012; N. Hayman, 
2010; Healthy Male, 2018c). Other recommendations for engaging Aboriginal and Torres 
Strait Islander males in general, or specifically for sexual health, derived from a range of 
studies and commentaries (M. Adams, 2014; Arney & Westby, 2012; K.  Canuto et al., 
2018; K. Canuto et al., 2018; Davy et al., 2016; N. Hayman, 2010; Healthy Male, 2018c; 
Tsey et al., 2014; Wenitong et al., 2014), include: 
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Health service level 
• consultation with the local community to understand their needs and create 
partnerships 
• good policies and practices based on evidence are in place at the establishment 
of a health service 
• linkages to other relevant health services and referral pathways for specialist 
treatment  
• employment of more ATSIHWPs, particularly males 
• male healthcare providers are available for male health clinics 
• training in male health topics for ATSIHWPs, particularly males, in accredited 
programs as part of broader primary healthcare training  
• support to ATSIHWPs given that their responsibilities often extend beyond the 
clinic out into the community and for times outside of clinic hours 
• education and skills development of staff in health services to change negative 
views and stereotypes about Aboriginal and Torres Strait Islander male patients 
• avoidance of high turnover of staff (often the case in remote communities) 
• cultural competency training for staff, in particular the cultural processes around 
gender and family, including an appreciation of the traditional and localised 
notions of the complementary nature of the rights, roles and responsibilities of 
males and females    
• orientation of specific services to males  
• culturally appropriate waiting rooms (especially for males) with health posters, 
paintings and artefacts to make it a welcoming and safe place  
• confidentiality protocols, particularly in small communities, that are 
communicated to patients 
• male-only times or places to discuss sensitive health issues, including out-of-
hours clinics 
• minimal waiting times while having a flexible approach so that other priorities that 
may arise, such as cultural responsibilities, can be attended to 
• provision of longer consultations for males to have time to discuss sexual health 
as well as general health issues 
• allowance for second or third consultations so that a relationship can be built with 
a male patient to allow discussions of a sensitive nature. 
Person level 
• strong relationships between males and healthcare providers and administration 
staff (for both non-Indigenous and Aboriginal and Torres Strait Islander staff) 
• sustained relationships so that trust can be built over time 
• the knowledge and confidence of healthcare providers to sensitively discuss 
sexual health with males 
• encouragement of non-Indigenous healthcare providers to invite ATSIHWPs 
(preferably males) to work with them and their male patients where appropriate 
• non-Indigenous healthcare providers with an understanding of the cultural and 
historical determinants of Aboriginal and Torres Strait Islander male health as the 
context of the health status of their patients 
• confidentiality in the practice of healthcare providers and reassurance of male 
patients that confidentiality is a priority 
• use of simple, straightforward language by healthcare providers, avoidance of 
medical jargon and appropriate patient resources to aid understanding and 
reduce anxiety 
• normalisation of sexual health issues to reduce shame and stigma 
• word of mouth promotion of the availability and need for males to attend health 
services. 
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Holistic approach to male health 
The 2010 National Male Health Policy (the Policy) emphasised the importance of the social 
determinants of health as drivers of health inequality for males in Australia, and particularly 
for Aboriginal and Torres Strait Islander males (Australian Government Department of 
Health and Ageing, 2010b). Since the launch of the Policy, through the National men’s 
health strategy 2020-2030 (Australian Government Department of Health, 2020) and the 
National Aboriginal and Torres Strait Islander Health Plan 2013-2023 (the Health Plan) 
(Australian Government Department of Health and Ageing, 2013), the Australian 
Government is increasingly acknowledging that cultural determinants of health are equally 
important for Aboriginal and Torres Strait Islander people (Australian Government 
Department of Health, 2017). According to the 2017 My life my lead report (Australian 
Government Department of Health, 2017): 
The cultural determinants of health encompass the cultural factors that 
promote resilience, foster a sense of identity and support good mental 
and physical health and wellbeing for individuals, families and 
communities. While the concept of cultural determinants of health is 
less understood than the social determinants of health, strong evidence 
is emerging on the various ways that culture can support better health 
outcomes. (p. 7) 
Aboriginal and Torres Strait Islander males have cultural roles, histories, and 
experiences, that are linked to their current health status. Aboriginal and Torres Strait 
Islander health policies, government health plans and health services all support the notion 
of a holistic approach to healthcare for Aboriginal and Torres Strait Islander people (and 
males in particular), that encompasses social and cultural determinants of health, and 
extends beyond the individual to the community. The National Aboriginal and Torres Strait 
Islander Male Health Framework adopted the 1989 Aboriginal Health Strategy definition of 
Aboriginal health (National Aboriginal Health Strategy Working Party, 1989) to underpin its 
second guiding principle of a 'holistic approach to male health' (Australian Government 
Department of Health and Ageing, 2010a): 
Aboriginal health means not just the physical wellbeing of an individual 
but refers to the social, emotional and cultural wellbeing of the whole 
Community in which each individual is able to achieve their full potential 
as a human being thereby bringing about the total wellbeing of their 
Community. It is a whole of life view and includes the cyclical concept 
of life-death-life. (p. 2) 
A holistic approach that includes the diversity of spiritualities, political beliefs, 
economic status, sexualities and lifestyles that are part of Aboriginal and Torres Strait 
Islander communities is seen as vital for improving the health of Aboriginal and Torres Strait 
Islander males (Australian Government Department of Health and Ageing, 2010a; Prehn & 
Ezzy, 2020). It follows then, although not stated overtly, that a holistic approach should 
include male sexual health, and all the factors (cultural, social, physical, psychological) that 
have an impact on sexual health and wellbeing. 
The way forward 
In a recent commentary, Kootsy Canuto eloquently described the necessary change in 
focus if there is to be a move towards better health and wellbeing for Aboriginal and Torres 
Strait Islander males (K. Canuto, Harfield, Wittert, & Brown, 2019):    
We need to stop describing problems and blaming individuals, and start 
acknowledging Aboriginal and Torres Strait Islander men as the 
dynamic, essential elements of families, communities and societies 
they have always been. The inherent personal and cultural strengths 
and attributes of Aboriginal and Torres Strait Islander men must be 
unshackled, and positive energy directed towards the development of 
new ways forward by men and their communities, who are empowered 
and supported to do so. (p. 308) 
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Respectful practices that non-Indigenous and Aboriginal and Torres Strait Islander 
healthcare providers can use to engage with male patients and each other are needed. 
Based on the experience of a range of healthcare providers, a framework addressing the 
approach, skills and personal attributes of healthcare providers, including practical 
strategies, that any healthcare provider cane use to develop respectful practice (Wilson et 
al., 2020). The Australian Health Minister’s Advisory Council’s National Aboriginal and 
Torres Strait Islander Health Standing Committee’s National Cultural Respect Framework 
2016-2026 for Aboriginal and Torres Strait Islander health provides a framework at a much 
broader level for developing respectful health services, from policy and legislation, to how 
organisations are run, through to the planning and delivery of services (Australian Health 
Ministers’ Advisory Council’s National Aboriginal and Torres Strait Islander Health Standing 
Committee, 2016). 
Other approaches to addressing male health disparities could include: 
• adoption of a 'decolonised', holistic approach to Aboriginal male health to move 
away from the individualised western biomedical view of health and address the 
social and cultural determinants of male health (Prehn & Ezzy, 2020) 
• development and promotion of interventions that empower men, such as men's 
camps, men’s health clinics, men’s sheds, based on the success of already 
existing programs (M. Adams, 2014; K. Canuto et al., 2019; Prehn & Ezzy, 2020; 
Wenitong, 2002) 
• ensuring cultural safety through workforce training, changing the clinical 
environment and engaging Aboriginal and Torres Strait Islander male health 
workers (Davy et al., 2016; Gee et al., 2014; Tremblay et al., 2020; Wilson et al., 
2020), with potential for positive effects on patient outcomes; such training could 
be adapted for male-specific services in chronic disease and sexual health 
• catering to the diversity of Aboriginal and Torres Strait Islander communities, not 
a one-size-fits-all approach (Australian Government Department of Health and 
Ageing, 2010a; Davy et al., 2016; Prehn & Ezzy, 2020). For example, the 
differing needs of men in remote, rural and urban areas 
• health services developed with the community and embedded in the community 
(Davy et al., 2016; Gee et al., 2014) 
• a gendered approach to male healthcare (M. Adams, 2014; Arney & Westby, 
2012; K.  Canuto et al., 2018; K. Canuto et al., 2018; Prehn & Ezzy, 2020; 
Thomson et al., 2010) 
• use approaches that are successful in improving engagement with primary health 
services, for example, the Inala Indigenous Health Service (N. Hayman, 2010; N. 
E. Hayman, Askew, & Spurling, 2014)  
• programs for male health delivered through ACCHOs (Gee et al., 2014). 
There is now a need to adopt approaches identified in multiple studies, to improve the 
health of Aboriginal and Torres Strait Islanders males, particularly with respect to sexual 
health and chronic disease. A recent commentary has put out the call to primary healthcare 
services to ‘collaborate, listen and understand’ as the time for action is now (K. Canuto et 
al., 2019). Some frameworks referred to above may be helpful if adapted specifically to 
health services for male patients, although they have not yet been evaluated (Davy C.  et 
al., 2017; Wilson et al., 2020). 
Prevention, awareness initiatives, programs and services 
There are currently no prevention programs, awareness initiatives or services that focus 
specifically on Aboriginal and Torres Strait Islander male sexual health (except for those 
related to sexually transmitted infections). However, there are programs and services for 
male health in general that could be vehicles for male sexual health initiatives. In addition, 
cultural competency training for healthcare providers could potentially encompass cultural 
factors that are particularly relevant to male sexual health. 
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Male-specific programs and male spaces 
In 2017-18, there were 134 primary healthcare organisations providing ‘men’s group’ 
programs or activities for Aboriginal and Torres Strait Islander males across Australia 
(Australian Institute of Health and Welfare & National Indigenous Australians Agency, 
2020). Some examples of male-specific programs that could be relevant to engaging males 
about their sexual health are listed in Table 8. 
Table 8. Aboriginal and Torres Strait Islander male health programs in Australia, 2021 






Builds healthy and supportive 
relationships through regular 
activities that focus on cultural 
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Supports the development of 
strong male Aboriginal youth 
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circles, explicit instruction, 
peer led participatory 
approaches and hands-on 
interactive activities, offered 
in local language/s and 
English. Sexuality and health 









Provides opportunities to 
gather socially and to 
culturally connect with other 
Aboriginal and Torres Strait 
Islander males, as well as 




Source: Australian Indigenous HealthInfoNet database of programs (2021) (Budja Budja Aboriginal 
Co-operative, 2021; BushTV, 2021; Central Australian Aboriginal Congress, 2021; Danila Dilba 
Health Service, 2021; Griffith Aboriginal Medical Service, 2021; Gurriny Yealamucka Health Service 
Aboriginal Corporation, 2021; Jo Thompson Consulting, 2019; Kirrip, 2021; Rekindling the Spirit, 
2021; Wurli Wurlinjang Health Service, 2021) 
These programs all have similar underlying philosophies: empowerment, social 
support, strengthening culture, ‘yarning’ and providing a culturally safe space (Arney & 
Westby, 2012). 
Cultural competency training 
Cultural competency is ‘…a key strategy for reducing inequalities in healthcare access and 
improving the quality and effectiveness of care for Indigenous people…’ (p. 2) (Bainbridge, 
McCalman, Clifford, & Tsey, 2015). Cultural competency is more than cultural awareness 
and should encompass behaviours, attitudes, and policies for effective cross-cultural work 
at the level of systems, agencies and healthcare providers (Bainbridge et al., 2015). 
Cultural competency training to support male health is vital for non-Indigenous 
healthcare providers and services, especially for those practising in the areas of male 
sexual health, which has specific cultural sensitivities (Healthy Male, 2018c). There are no 
specific training programs for those whose practice involves Aboriginal and Torres Strait 
Islander male sexual health. However, cultural competency training for other areas of 
health may be adaptable to the needs of male patients with sexual health conditions and 
chronic disease. There is presently a lack of robust evidence for the effectiveness of cultural 
competency interventions, particularly with respect to patient outcomes (Bainbridge et al., 
2015; Clifford, McCalman, Bainbridge, & Tsey, 2015), apart from some work in diabetes 
management (Tremblay et al., 2020). The development of any competency training for 
Aboriginal and Torres Strait Islander male sexual health will need evaluation embedded 
into the program. 
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This review illustrates a lack of knowledge about the links between male sexual health and 
general health, particularly in the development of chronic disease. It also highlights a lack 
of, and barriers to accessing, sexual health services for Aboriginal and Torres Strait 
Islander males. Addressing the three levels of 'silence' identified by Adams in the only male 
sexual health study conducted to date (M. Adams, 2014; M. J. Adams et al., 2013) 
(research level, healthcare provider level and community level) provide a framework for 
thinking about future directions to improve this situation. 
Research 
The lack of data on sexual health in Aboriginal and Torres Strait Islander males, identified 
in a 2002 review (Wenitong, 2002) remains a barrier to improving male health and 
wellbeing. The single study to date has provided rich data about the extent of specific 
sexual health conditions in several communities in the NT and Qld, as well as insights into 
the reasons for silence about sexual health and barriers and enablers for engaging with 
services (M. Adams, 2014; M. J. Adams et al., 2013). Far more work is needed to 
understand the extent of sexual health problems of Aboriginal and Torres Strait Islander 
males across the country and the links with chronic disease, as well as the best approaches 
for bringing sexual health into general healthcare through culturally appropriate and 
gender-specific services. 
As an Aboriginal and Torres Strait Islander man, Adams (M. Adams, 2014) wrote about 
the importance for males in communities to have genuine ownership of the research project 
he conducted, his role in facilitating the dissemination of information about the study, and 
ensuring cultural protocols were in place. This study provides a model for how research on 
a sensitive topic as sexual health can be conducted (M. Adams, 2014). All researchers 
need to consider their protocols to ensure there are no inherent barriers to the inclusion of 
Aboriginal and Torres Strait Islander males in any type of research study. 
The types of research that could be useful in the male sexual health context include: 
• prevalence and incidence studies 
• investigation of links between sexual health and chronic disease in Aboriginal and 
Torres Strait Islander communities 
• identification of barriers and enablers to seeking or obtaining sexual healthcare, 
both from the perspective of healthcare providers and of Aboriginal and Torres 
Strait Islander males 
• intervention studies to trial and evaluate approaches to improving access to 
services and engagement with males about sexual health, including cultural 
competency interventions 
• examination of strategies to encourage the inclusion of sexual health into general 
health checks and chronic disease assessment and management in Aboriginal 
and Torres Strait Islander males. 
Healthcare providers 
One measure of progress can be seen in the commitment of health services to provide culturally 
safe health care. In 2017–18, 95% of Indigenous-specific primary health care providers had in 
place a formal commitment to providing culturally safe health care, and approximately half 
(49%) of their health care workers identified as Aboriginal and/or Torres Strait Islander 
(Australian Institute of Health and Welfare, 2020a). To incorporate sexual health into general 
health consultations with Aboriginal and Torres Strait Islander clients, requires taking further 
steps to ensure healthcare providers have the knowledge and training to feel comfortable and 
competent to start the discussion. However, there are few education or awareness programs 
for healthcare providers specifically related to male health in general, or sexual health in 
particular, apart from the Healthy Male resource: A lot of Aboriginal men sort of keep it to 
themselves: Communicating specific Men’s Business (Andrology Australia, 2013) (found at: 
https://www.healthymale.org.au/health-professionals/professional-education/aboriginal-and-
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torres-strait-islander-health). Among primary healthcare providers, knowledge of sexual health 
conditions is often low and there is a general lack of awareness of links with cardiovascular 
disease and T2DM. General practitioners, ATSIHWPs and nurses could all benefit from specific 
awareness or training programs, but the best way to deliver these will likely depend on the 
needs of the healthcare provider and service, and the local community where the health service 
is located.  
One model of male health training for ATSIHWPs has been evaluated and the findings 
could inform broader dissemination of such training (Tsey et al., 2014). A male health 
module (developed by Healthy Male) was piloted in three workshops; one with potential 
trainers of health workers; one with male health workers; and one with both male and 
female health workers. The participants overwhelmingly felt the course was relevant to their 
work and filled a gap in workforce training. The holistic approach underpinning the module 
was consistent with Aboriginal and Torres Strait Islanders' way of thinking. Importantly, 
participants felt the training enhanced their personal development and sense of 
empowerment (Tsey et al., 2014). However, there was concern that health workers face 
barriers to participating in such training, including having too many training programs for a 
limited number of health workers, not being able to take time off work to attend, and the 
difficulty of catering to the range of health workers across the country (Tsey et al., 2014). 
Aboriginal and Torres Strait Islander males and communities 
In response to the identified barriers to health service use and discussions among males 
in communities about sexual health, there is a great need for health promotion and 
awareness programs to de-stigmatise sexual health and encourage males to seek help 
when they have a problem. Understanding the links between sexual health and CVD and 
T2DM, including the common risk factors, may provide an additional motivator for males to 
seek help (M. Adams, 2014; Wenitong et al., 2014).  
The importance of involving health professionals and Aboriginal and Torres Strait 
Islander people in the development of health promotion and education programs is 
highlighted in the National Aboriginal and Torres Strait Islander Health Plan 2013-2023 
(Australian Government Department of Health and Ageing, 2013). There is a pressing need 
for health promotion programs relating to male sexual health and chronic disease. While 
there are programs aimed at raising awareness about sexually transmitted infections 
among Aboriginal and Torres Strait Islander people (for example, Condoman (2Spirits 
Program, 2018)), there are none for sexual health conditions associated with CVD and 
T2DM.  
A review of health promotion programs aimed at modifying chronic disease risk factors 
showed a lack of evaluation. Moreover, most programs focused on changing individual 
behaviours rather than the broader context of health, such as supportive environments and 
health services, in apparent disregard for the holistic approach to health that is necessary 
to achieve the desired outcomes (K. J. Canuto et al., 2021). Any programs that are 
developed to increase awareness and knowledge of male sexual health and chronic 
disease need to incorporate the wider context of Aboriginal and Torres Strait Islander male 
health and be based on an empowerment model that involves the local community as well 
as healthcare providers and services, and must include evaluation. The review found that 
programs delivered through ACCHOs had the advantage of fostering community 
involvement and empowerment (K. J. Canuto et al., 2021). 
Possible strategies for incorporating male sexual health into chronic 
disease care, prevention and health promotion 
Raising the awareness of males and healthcare providers about male sexual health 
conditions and the links with chronic disease is a basic requirement before there can be 
any change in help-seeking or health service provision. As a starting point, The National 
Aboriginal and Torres Strait Islander Male Health Framework - Revised Guiding Principles 
(Australian Government Department of Health and Ageing, 2010a) provides a solid basis 
on which to address the health of Aboriginal and Torres Strait Islander males: it emphasises 
a gender-specific, holistic approach, that provides opportunities for reconstructing male 
empowerment and self-determination.  
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Including sexual health assessments in general health checks could be a simple and 
effective strategy. Moreover, sexual health could be incorporated into annual preventive 
health assessments for Aboriginal and Torres Strait Islander people (MBS item 715) 
(National Aboriginal Community Controlled Health Organisation & Royal Australian College 
of General Practitioners, 2018). Once the links between sexual health conditions and 
chronic disease are better understood, and the potential for improving both sexual health 
and general health through risk factor prevention and management is realised, healthcare 
providers may see the benefit of a more holistic approach to their male patients (Healthy 
Male, 2018c; Wenitong et al., 2014). 
Developing and designing interventions and services for male sexual health within 
current frameworks would support the holistic health and wellbeing of Aboriginal and Torres 
Strait Islander males. Most Aboriginal and Torres Strait Islander primary healthcare 
services manage male patients with CVD and T2DM and other chronic health conditions 
(Australian Institute of Health and Welfare, 2012). The Aboriginal and Torres Strait Islander 
Health Performance Framework 2020 summary report found that in 2018-19, 248,800 
Aboriginal and Torres Strait Islander people accessed an Indigenous-specific health check 
and 82% of Aboriginal and Torres Strait Islander males reported having consulted a GP or 
specialist doctor in the previous 12 months, with 44% reporting they had discussed lifestyle 
issues with the health professional (Australian Institute of Health and Welfare, 2020a). In 
very remote areas, 75% of those who attended a health service went to an Aboriginal 
Medical Service (AMS) or community clinic in 2017-18 (Australian Institute of Health and 
Welfare, 2020a). These findings show positive utilisation of Indigenous-specific health 
services and support the incorporation of male sexual health into chronic disease 
management in primary healthcare services (such as AMSs) in consultation with ACCHOs.  
Upskilling healthcare providers so they can confidently and competently facilitate 
sensitive clinical encounters with male patients and manage male sexual health conditions 
is another key strategy to improve the current ‘silence’ on this front. Training programs that 
specifically target health workers can have wider effects due to the role of health workers 
as agents of change in Aboriginal and Torres Strait Islander primary care. Such training 
may also makes it more attractive for Aboriginal and Torres Strait Islander males to enter 
a health workforce traditionally dominated by women (Tsey et al., 2014). As identified in 
the pilot study of a male health module for ATSIHWPs, barriers to participating in training 
programs also need to be addressed before there will be widespread uptake (Tsey et al., 
2014). 
Policies and funding 
Policy responses at all levels of government are required to improve the health of Aboriginal 
and Torres Strait Islander male health (Prehn & Ezzy, 2020). At present, there is a lack of 
specific policy actions to address the well-documented poor health outcomes for Aboriginal 
and Torres Islander males. Apart from the National Aboriginal and Torres Strait Islander Male 
Health Framework - Revised Guiding Principles (Australian Government Department of 
Health and Ageing, 2010a), other federal policies (the National Aboriginal and Torres Strait 
Islander Health Plan 2013-2023 (Australian Government Department of Health and Ageing, 
2013) and the National Men’s Health Strategy 2020–2030 (Australian Government 
Department of Health, 2020)), do not include specific strategies to improve Aboriginal and 
Torres Strait Islander male health, or the necessary funding commitments. At a local health 
district level, the Northern Sydney Local Health District Aboriginal and Torres Strait Islander 
Men’s Health Plan 2015-2020 (Northern Sydney Local Health District, 2015) is a possible 
template for other local health districts to develop specific strategies to improve Aboriginal 
and Torres Strait Islander male health (Prehn & Ezzy, 2020). 
Complicated funding pathways, short-term funding, and sudden loss of funding are 
barriers to implementing and sustaining health interventions in Aboriginal and Torres Strait 
Islander health in general (Gibson et al., 2015) and male health in particular (K. Canuto et 
al., 2019; Prehn & Ezzy, 2020), although some strategies for improving engagement of 
males with healthcare services can be low-cost (K. Canuto et al., 2019; Gibson et al., 2015; 
Prehn & Ezzy, 2020). The NACCHO 10-point plan identified the development of a funding 
strategy as a key step to success to achieving their 2030 vision (National Aboriginal 
Community Controlled Health Organisation, 2013). The design phase of any interventions 
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to address male sexual health and chronic disease would therefore need to identify specific 
and sustainable funding streams to give the intervention the best chance of success. 
Concluding comments 
The links between male sexual health and chronic conditions are well established, 
however, there is poor knowledge and awareness of male sexual health and the links 
with general health among both health professionals and Aboriginal and Torres Strait 
Islander males. In addition, there is a lack of research and data about sexual problems 
among Aboriginal and Torres Strait Islander males and how they are managed. There is 
clearly a need to improve knowledge about male sexual health in Aboriginal and Torres 
Strait Islander communities to guide health promotion programs and health services. The 
growing evidence base about the links between male sexual health and general health, 
including shared risk factors can provide opportunities to address not only sexual health 
concerns of males but also potentially improve their general health.  
Strategies such as the inclusion of sexual health in general health assessments, 
utilising existing services and programs to create awareness of sexual health and address 
sexual problems among males, and the development and supported implementation of 
culturally appropriate training for healthcare providers working with Aboriginal and Torres 
Strait Islander males are some key strategies recommended in this review to improve 
health service provision in this area and address some of the barriers to access faced by 
Aboriginal and Torres Strait Islander males.  
This review outlines the mounting evidence that ED can be a sign of future CVD or 
T2DM. This is an important message that has the potential to motivate males of all ages 
to seek help if they experience ED, and for health professionals to become skilled in 
discussing sexual health with their male patients. The latter requires further consideration 
of cultural factors for Aboriginal and Torres Strait Islander males and the social and 
historical context in which their health and wellbeing exists.    
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A male sex hormone such as testosterone responsible for the development of male 
characteristics 
Androgen deficiency  
A clinical diagnosis made when a male has low levels of serum testosterone detected on 
two separate occasions. (See also Low testosterone) 
Atherosclerosis 
A process that results in the build-up of plaques or deposits in arteries that may lead to 
obstruction of blood flow 
Cardiovascular disease 
The term for all of the diseases and conditions that affect the heart and blood vessels 
Diabetes 
A metabolic disorder where blood glucose levels are imbalanced 
Endocrine system 
The system of glands (including the pituitary, thyroid, adrenals, testes) which secrete their 
products (hormones) into the blood stream 
Endocrinologist 
A doctor who specialises in problems in the endocrine system (hormones and hormonal 
function) 
Erectile dysfunction 
An ongoing problem getting and maintaining an erection that is firm enough for sexual 
intercourse 
Hormone 
A substance that circulates through the body in the blood stream and promotes growth, 
reproduction and general well-being 
Hypogonadism 
An inability of the testes to produce high enough levels of testosterone (androgen 
deficiency) and/or sperm (spermatogenesis) 
Klinefelter syndrome 
A chromosome problem that causes low testosterone levels, breast development, small 
testes and infertility in men 
Low testosterone  
A condition where a male cannot produce enough testosterone for his body to function 
normally. Clinically defined by a lower-than-normal serum testosterone level. (See also 
Androgen Deficiency) 
Luteinizing hormone (LH) 
A hormone produced by the pituitary gland which stimulates the production of 
testosterone in the testes 
Micropenis 
Abnormal smallness of the penis. Micropenis occurs when the penis fails to grow for the 
last two-thirds of the embryo’s development 
Morbidity 
An illness or abnormal condition 
36





Type of drug which contains nitric acid 
PBS (Pharmaceutical Benefits Scheme) 
Australian Government program for the subsidy of prescribed essential drugs, to provide 
them cheaper to the consumer 
PDE5 (phosphodiesterase) inhibitors 
Family of drugs used for treating erectile dysfunction by promoting the body’s natural 
response to sexual stimulation 
Penile 
Relating to the penis 
Penis 
Male organ for urination and sexual intercourse. 
Peyronie’s disease 
Build-up of plaques around the core of the penis, which can lead to change in shape and 
painful erections 
Prostate 
A gland within the male reproductive system that is located just below the bladder 
Risk factor 
An aspect of lifestyle or behaviour, a health condition, an environmental exposure or an 
inborn or inherited characteristic, known to be linked with health-related conditions 
considered important to prevent 
Serum 
The clear liquid that can be separated from clotted blood 
Sex-hormone binding globulin 
A protein produced by the liver that binds sex hormones (testosterone and oestradiol) in 
the blood 
Sperm 
Mature male sex cell 
Testicle/testis (plural: testes) 
The male reproductive organ that produces sperm and the male sex hormones 
Testicular function 
The ability of the testicles to produce sperm and testosterone 
Testosterone 
Male sex hormone 
Vascular 
Conditions involving blood vessels 
 
Most of the terms listed in this glossary have been sourced from a glossary published on 
the Healthy Male website which can be accessed here: 
https://www.healthymale.org.au/resources-tools/glossary  
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Appendix 1 – Limitations 
Aboriginal and Torres Strait Islander status 
Identification of individuals as Aboriginal and Torres Strait Islanders is a problem across all 
administrative datasets, resulting in an under-estimate of their number in any given dataset 
involving both non-Indigenous and Aboriginal and Torres Strait Islander people. There has 
been some improvement in the identification of Aboriginal and Torres Strait Islander people 
in recent years and strategies are in place to improve recording of Indigenous status 
(Northern Sydney Local Health District, 2019; RACGP National Faculty of Aboriginal and 
Torres Strait Islander Health, 2011). 
Sexual health conditions   
Apart from ED and low testosterone, other male sexual health conditions may be linked to 
CVD and/or T2DM but they have not been included in this review. For example, there is 
some evidence that lower urinary tract symptoms (LUTS) are associated with chronic 
conditions, particularly CVD, but the evidence on the nature of the associations is not yet 
clear (Blanker et al., 2016; Bouwman et al., 2015).  
Androgens and steroid abuse 
In the review of testosterone and CVD, androgenic steroid abuse (e.g., by body builders) 
is not included. While long-term androgenic steroid abuse may be associated with 
cardiovascular damage, in addition to other effects on the male reproductive system, the 
extent of the use or abuse of drugs or supplements for body-building or cosmetic purposes 
in Aboriginal and Torres Strait Islander males is not known.  
Hospitalisation data 
Statistics on hospitalisation provide some indication of the burden of disease in the 
population. They are, however, a poor reflection of the extent and patterns of treatable 
illness in the community because they only represent illness serious enough for 
hospitalisation, and are influenced to some extent by the geographic accessibility of 
hospitals and variations in admission policies and practices. As is the case with other major 
health-related data collections (such as births and deaths), the identification of Indigenous 
status in hospital data collections is incomplete. 
Another limitation of the available hospital statistics as indicators of the health of the 
population, is that they relate to episodes of hospitalisation rather than to individual 
patients. Also, it is difficult to analyse patterns of care for patients hospitalised multiple 
times (for example for kidney dialysis) from the current national hospitalisation data.  
Hospitalisation rates will be affected by advancements in the health system, 
improvements in self- identification by Aboriginal and Torres Strait Islander people, and 








Appendix 2 – Detailed review of studies of erectile dysfunction and 
low testosterone and links with cardiovascular disease and type 2 
diabetes  
Australian studies estimating the prevalence of erectile dysfunction 
Several studies have estimated the prevalence of ED in Australian men, albeit using a 
range of measures and population samples that precludes making direct comparisons (M. 
J. Adams et al., 2013; Banks et al., 2013; K. K. Chew et al., 2008; Holden et al., 2005; S. 
Martin et al., 2012; Schlichthorst et al., 2016; Weber et al., 2013; Wen et al., 2017). 
Only one study has reported ED among Aboriginal and Torres Strait Islander males 
specifically (M. J. Adams et al., 2013). In this 2004/2005 study of males aged 18 to 74 
years in communities across the Northern Territory (NT) and Queensland (Qld) (n=293), 
16% reported mild or mild-moderate ED and 14% had moderate-severe ED, with increased 
prevalence across age groups (M. J. Adams et al., 2013). Notably, moderate to severe ED 
was reported by around 10% of younger Aboriginal and Torres Strait Islander males (in 
both the 18 to 24 and 25 to 34 years age-groups). 
A study of a random sample of men in WA aged 20 to 99 years (n=1,580; recruited 
2001 to 2002) found the prevalence of 'any ED (from mild to severe)', adjusted for the age 
distribution of the WA population, was 25% and the prevalence of severe ED was 8.5% (K. 
K. Chew et al., 2008). There was a strong association with age: the prevalence of 'any ED' 
in men aged 20-29 was 16% and increased incrementally to 68% in men aged 80 years or 
older (severe ED ranged from 3% to 57%, respectively) (K. K. Chew et al., 2008). 
The MATeS study of a representative population sample of 5,990 Australian men aged 
40 years or over (recruited 2003) found one in five men reported moderate or severe ED, 
with prevalence ranging from 3% in men aged 40-49 years up to 68% in men aged 70 years 
or older (Holden et al., 2005). 
In the NSW '45 and Up' study’ of men aged 45 years and over with no prior diagnosis 
of prostate cancer (n=101,674; recruited 2006 to 2010), 19% had moderate ED and 17% 
had severe ED (Weber et al., 2013). There was a steep increase across age groups: 
prevalence of severe ED ranged from 2.2% for men aged 45-54 years to 75% in men 85 
years old and older (Banks et al., 2013). 
In a random sample of 1,195 community-dwelling men aged 35-80 years from SA (the 
FAMAS cohort, recruited 2002 to 2005), 18% reported moderate to severe ED, again with 
a sharp increase across age groups (S. Martin et al., 2012). 
In the Ten to Men longitudinal study of Australian men aged 18 to 55 years (n=12,636; 
recruited 2013 to 2014), 14% indicated they 'had trouble getting or keeping an erection' for 
at least three months in the previous 12 months (Schlichthorst et al., 2016). 
The Second Australian Study of Health and Relationships found 12% of the sample of 
sexually active men aged 16 to 69 years (n=9,611; recruited 2012 to 2013) had difficulty in 
keeping an erection during a period of one month or longer in the previous 12 months (Wen 
et al., 2017). 
Links between erectile dysfunction and cardiovascular disease 
Cross-sectional studies 
Many cross-sectional studies show that ED is more common in men with CVD and they 
share common risk factors, such as obesity, high blood glucose, hypertension (high blood 
pressure) and hyperlipidaemia (high cholesterol levels), or a combination of these 
(metabolic syndrome) (Gandaglia et al., 2014; Kaya, Sikka, & Gur, 2015). Although the 
temporal relationship between ED and CVD cannot be ascertained from cross-sectional 
data, identified associations combined with the possible common pathophysiological 
pathways, led to the hypothesis that ED is not only a consequence of chronic conditions 
but can pre-exist chronic disease, particularly CVD. 
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In addition to the many early studies demonstrating ED and CVD associations 
(Gandaglia et al., 2014), a more recent very large study from the United States of America 
(USA) (over 500,000 men with a diagnosis of ED and over 9 million men without a diagnosis 
of ED) using insurance claims data showed associations of ED with diabetes, depression 
and CVD, independent of possible confounding demographic factors (Goldstein et al., 
2018). Moreover, the relationships between ED and the other chronic conditions were 
evident in men as young as 30-39 years of age (Goldstein et al., 2018). 
Although most international studies have been done in populations of European 
ethnicity (including Australia, as described below) one study from the from the Pacific nation 
of the Solomon Islands, of men who were sexually active in the four weeks prior to 
assessment, showed that over half reported at least one type of sexual difficulty (including 
19% who experienced erectile difficulties 'sometimes' and 4.3% 'most times') (Lui, Dunne, 
Baker, & Isom, 2017). Sexual difficulties were associated with having a chronic health 
condition (diabetes, high blood pressure and/or heart disease), after adjusting for age. 
Notably, this was a relatively young population, with almost half aged 20-29 years (Lui et 
al., 2017). 
Australian studies 
The 2004/2005 study in Aboriginal and Torres Strait Islander males showed a strong 
association between moderate to severe ED and self-reported diabetes, heart disease and 
high blood pressure (M. J. Adams et al., 2013). 
An assessment of the associations between biomedical and lifestyle factors and 
reproductive health disorders in the MATeS study of men aged 40 years and older showed 
(self-reported) diabetes and CVD, but not hypertension, were associated with ED (Holden, 
McLachlan, et al., 2010). Depression, sedentary lifestyle and being underweight or obese 
were also associated with ED in age-adjusted models (Holden, McLachlan, et al., 2010). 
In the FAMAS cohort of men aged 35-80 years in SA, increasing age, abdominal fat mass, 
obstructive sleep apnoea risk, and the absence of a regular partner were associated with 
both mild and moderate-severe ED (S. Martin et al., 2012). Furthermore, insufficient 
physical activity, low risk19 alcohol consumption, and hypertension were associated with 
mild ED, and voiding lower urinary tract symptoms, diabetes, and lower plasma 
testosterone were independently associated with moderate-severe ED (S. Martin et al., 
2012). 
A study of NSW men from the '45 and Up' cohort showed that in those aged 45 and 
over with no prior diagnosis of prostate cancer, the prevalence of moderate/complete ED 
was higher among those with low socioeconomic status, high body mass index, sedentary 
lifestyle, were current smokers and those with diabetes, heart disease, and 
depression/anxiety, compared with men without these risk factors (Weber et al., 2013). 
Moderate alcohol consumption was associated with a significantly reduced prevalence of 
ED in men aged 45-54 years, but not in older men (Weber et al., 2013). 
A study using data from the Ten to Men longitudinal study of Australian men found 
associations between 'trouble getting or keeping an erection' and cigarette smoking, 
alcohol consumption, some drug use, obesity (older men only), self-rated health lower than 
'excellent', daily pain self-medication (older men only), having a disability (older men only), 
and having a diagnosis of one or more physical or mental health conditions in men aged 
18 to 55 years (Schlichthorst et al., 2016). 
Longitudinal studies 
Many longitudinal (most prospective, some retrospective) studies support the hypothesis 
that ED predicts the onset of CVD some years later (Zhao et al., 2019). One of the first 
prospective studies, published in 2005, showed that men aged 55 years or over with 
prevalent (present at baseline) or incident ED (n=8,063) had a 45% greater risk (HR=1. 45) 
 
19  According to Australian National Health and Medical Research Council (2001) Australian alcohol 
guidelines: health risks and benefits, low risk alcohol consumption was defined as: up to six standard drinks 
on any one day, no more than three days per week. 
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of experiencing a cardiovascular event than men without ED during the seven-year study 
(Thompson et al., 2005). By one year following a report of ED, 2% of men had experienced 
a cardiovascular event and by five years this rose to 11% (Thompson et al., 2005). The 
authors concluded that ED had an effect on subsequent cardiovascular events equal to or 
greater than a family history of myocardial infarction (heart attack), cigarette smoking, or 
hyperlipidaemia (high levels of lipids such as cholesterol in the blood) (Thompson et al., 
2005). A possible limitation is that the study population was a selected group of adult males 
in the USA participating in the placebo arm of a prostate cancer prevention trial (Thompson 
et al., 2005). 
Another widely quoted longitudinal study, published in 2009, used data from a USA 
population sample of men aged 40 years or over (n=1,402) followed for 10 years (Inman et 
al., 2009). After adjustment for common CVD risk factors in those with no known CAD at 
baseline, there was about an 80% increased risk of developing CAD over 10 years for men 
with ED compared to those without (Inman et al., 2009). An important finding from this 
study was that the association between ED and CAD was much stronger at younger ages: 
men aged 40-49 years with ED had about double the risk compared to those without ED 
(adjusted HR=2.1) and the risk conferred by ED decreased across age-groups. In men 
aged 70 years or over, ED had very little effect on the incidence of CAD (Inman et al., 
2009). 
Another USA study of a population sample of men aged 40-70 years without CVD or 
diabetes (n=1,057) found that ED predicted the development of CVD over 12 years follow-
up: in models adjusted for established risk factors, men with ED had a 40% higher risk of 
developing CVD (including a wide range of CVD end-points), compared to men without ED 
(Araujo et al., 2010). Many USA studies include predominantly white men. However, an 
analysis of the 'Multi-Ethnic Study of Atherosclerosis' (n=1,757 men with a mean age of 69 
years and no CVD followed for 3.8 years) showed ED was a predictor of CVD events, 
including CHD and stroke, after adjusting for traditional CVD risk factors, depression and 
use of beta-blockers (hypertension medication) (Uddin et al., 2018). The odds for a CVD 
event in men with ED at baseline was about twice that for men without ED. This study also 
showed that men who developed CVD during the study had a higher chance of also 
developing ED (Uddin et al., 2018). 
Australian studies 
A retrospective WA study (ED diagnosed between Jan 1995 and Dec 2004) linked data on 
men aged 20 years or older with ED and no reported atherosclerotic CVD (n=1,660) to 
administrative hospital data and death records (up to 2005) to determine hospitalisations 
and/or death from CVD over a 10-year period (K. Chew et al., 2010). The incidence of 
atherosclerotic CVD events (those due to narrowing or hardening of the arteries) in the 
study population was more than two times higher than men in the general WA male 
population (K. Chew et al., 2010). Interestingly, 12% of men in the study had their first-ever 
event within five years of developing ED (K. Chew et al., 2010). 
Tobacco smoking, presence of comorbidities (other health problems) and 
socioeconomic disadvantage were associated with a stronger link between ED and later 
development of CVD. An age effect was also identified: incidence rates of CVD for men 
with ED were significantly higher than the incidence rates in the general population in all 
age groups younger than 70 years; however, the difference in CVD incidence between the 
men with ED and the general population was greater in younger men (K. Chew et al., 2010). 
This age effect supported the findings from the USA study (Inman et al., 2009). 
A study of NSW men from the '45 and Up' cohort (n=95,038) linked questionnaire data 
to hospitalisation and death data, with a mean follow-up time of 2.2 years for hospital 
admission and 2.8 years for deaths (Banks et al., 2013). For men with no CVD at baseline, 
severe ED (compared to no ED) conferred increased risks of IHD (relative risk (RR20)=1.6), 
heart failure (RR=8.0), peripheral vascular disease (RR=1.9), all CVD combined (RR=1.4) 
 
20  RR = relative risk. This gives an estimate of the increased risk of developing CVD in men with ED 
compared to those without ED. For example, RR=1.6 means that men with severe ED had 1.6 times the 
chance of developing CVD than men with no ED. 
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and deaths from all causes (RR=1.9), but not primary hypertension or intracerebral 
haemorrhage (stroke caused by bleeding in the brain), after adjustment for the main CVD 
risk factors (Banks et al., 2013). Similar risks were identified for men with CVD at baseline. 
A novel finding from this study was a dose-response relationship between the severity of 
ED and the risk of CVD, that is, the risk of CVD was greater for those with more severe ED 
(Banks et al., 2013). 
Links between low testosterone and cardiovascular disease 
The fact that older men are more at risk of CVD and also more likely to have lower 
testosterone levels and be overweight, poses the question of whether lower testosterone 
is just a consequence of ill-health or whether low testosterone may be a marker or predictor 
of subsequent CVD, independent of other CVD risk factors. Reviews of current evidence 
suggest that this question has not yet been answered adequately and research is ongoing. 
Most studies so far have not had a sufficient sample size to make definitive conclusions 
about specific CVD outcomes, particularly CVD-related deaths, while adjusting for other 
possible explanatory factors (Yeap et al., 2021; Yeap, Page, & Grossmann, 2018; Yeap & 
Wu, 2019). Three reviews have assessed studies of associations between low circulating 
testosterone levels and CVD or deaths due to CVD or any cause, summarised below 
(Meyer & Wittert, 2018; Yeap et al., 2019; Yeap et al., 2018). 
Testosterone and cardiovascular disease 
Yeap (Yeap et al., 2018; Yeap & Wu, 2019) reviewed studies published between 2005 and 
2016 (n=16 studies) that examined associations between testosterone and various CVD 
outcomes. Studies varied with respect to sample size, follow-up time, age range, type of 
CVD measured and assays used to measure testosterone. Most studies adjusted their 
analyses for age, body mass index and other conventional CVD risk factors (Yeap et al., 
2018; Yeap & Wu, 2019). 
There was a mix of studies reporting positive associations, inconclusive results and 
negative results. The larger cohort studies using mass spectrometry to assay hormones (gold 
standard) tended to support an increased risk of CVD with lower testosterone (Yeap et al., 
2018; Yeap & Wu, 2019). 
The main findings from Yeap's reviews (Yeap et al., 2018; Yeap & Wu, 2019) are: 
• Studies examining sex hormones and composite measures of CVD events 
generally support an association between testosterone levels and risk of CVD 
events in middle-aged and older men, but possibly more so in older men. The 
association may be linear or U-shaped (where both low and high levels of 
testosterone predict CVD). 
• Studies examining fatal and non-fatal myocardial infarction (heart attack) did not 
show a convincing association with circulating testosterone levels. 
• Lower circulating testosterone levels are associated with having a stroke but 
whether it is a causative factor is not yet clear. 
Testosterone and deaths due to CVD or any cause 
Fourteen of the studies included in the reviews described in the previous section reported 
associations between testosterone levels and deaths due to CVD in mostly middle-aged or 
older men, although two studies included men aged 20 years and over (Yeap et al., 2018; 
Yeap & Wu, 2019). Despite conflicting findings, overall the studies reviewed support a modest 
association between low testosterone and death due to CVD, but again, a causal link is not 
yet established (Yeap et al., 2018; Yeap & Wu, 2019). 
A separate review of studies assessing associations between testosterone and dying 
from any cause concluded that men with lower testosterone levels have a higher risk of dying 
overall (from any cause), noting that CVD was the predominant cause of death in most 
studies (Meyer & Wittert, 2018). However, given that men with low testosterone are more 
likely to be obese and have metabolic disease it is difficult to determine whether the low 
testosterone is a reflection of a man's health status or whether it contributes causally to these 
conditions (Meyer & Wittert, 2018). 
42




In contrast, a recent study of nearly 150,000 men aged 40 to 69 years followed for 11 
years showed an association between low testosterone and deaths from any cause and 
cancer specifically, but not deaths due to CVD (Yeap et al., 2021). An association between 
low serum testosterone levels and CVD deaths was found in unadjusted analyses, but not 
once all other risk factors were taken into account. The large size of this study allowed for 
statistical adjustment for many CVD risk factors and sex hormones other than testosterone, 
which could explain why the association with CVD deaths has been found in other studies 
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